Fluorescent iPSC colony generated via CytoTune Sendai reprogramming.

从体细胞生成诱导多能干细胞 (iPSC) 不再是一项艺术;在 CytoTune-iPS 仙台病毒iPSC重编程试剂盒的帮助下它已然成为一门可以被预测的科学。直接从具有不同遗传背景的多种细胞类型(包括 PBMS 和 T 细胞)衍生细胞系我们的 CytoTune-iPS 2.0 仙台病毒重编程试剂盒可支持最为领先的基础研究,而我们的 CTS CytoTune 2.1 仙台病毒重编程试剂盒则有助于临床及转化研究。无论您处在过程中的哪一步,我们都可提供能支持您从研究直至商品化的重编程工具。


为何使用仙台病毒进行 iPSC 重编程?

  • 在多种细胞类型中具有较高的重编程效率
  • 无整合递送降低了基因组风险
  • 适用于疾病建模和转化研究
  • 与基于质粒的方法相比,具有更好的可重复性和可扩展性


仙台病毒重编程与其他方法相比如何?

  • 仙台病毒:高效率、无整合、瞬时RNA
  • 维持型载体:无整合,但效率较低
  • mRNA重编程:无整合,需要每日转染
  • 慢病毒方法:高效率但会整合入基因组


CytoTune iPS 2.0 仙台病毒重编程试剂盒——在非整合型重编程技术中成功率较高

  • 对成纤维细胞和血液重编程均具有最高成功率
  • 用最少的手动操作时间完成可扩展的细胞系生成
  • RNA 载体清除迅速


CTS CytoTune-iPS 2.1 仙台病毒重编程试剂盒——高效过渡至临床应用

  • 根据 GMP 的规定生产
  • 不含动物源成分
  • 附带监管支持文件(RSF),以支持您的监管申报


CytoTune Sendai 重编程试剂盒订购信息


使用 CytoTune-iPS 试剂盒减少动手操作时间

下图展示了使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒对人新生儿包皮成纤维细胞进行重编程,以生成在 MEF 饲养层细胞上培养的 iPSC 所需的主要步骤。

下图展示了使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒将外周血单个核细胞(PBMC)重编程并在 MEF 饲养层细胞上培养以生成 iPSC 所需的主要步骤。

使用 CytoTune-iPS Sendai 重编程试剂盒从人新生儿包皮成纤维细胞(BJ 株)简单生成 iPSC 克隆

(A) 转导前的成纤维细胞。(B-D) 使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒单次处理后,转导后 (B) 2 周和 (C) 3 周的 iPSC 克隆可因重编程效率高且部分重编程细胞背景低而被轻松识别。(D) 手动挑取并转移至 KnockOut SR 培养基后的 iPSC 克隆。

下图展示了使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒对人新生儿包皮成纤维细胞进行重编程,以生成在 MEF 饲养层细胞上培养的 iPSC 所需的主要步骤。

下图展示了使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒将外周血单个核细胞(PBMC)重编程并在 MEF 饲养层细胞上培养以生成 iPSC 所需的主要步骤。

使用 CytoTune-iPS Sendai 重编程试剂盒从人新生儿包皮成纤维细胞(BJ 株)简单生成 iPSC 克隆

(A) 转导前的成纤维细胞。(B-D) 使用 CytoTune-iPS 2.0 Sendai 重编程试剂盒单次处理后,转导后 (B) 2 周和 (C) 3 周的 iPSC 克隆可因重编程效率高且部分重编程细胞背景低而被轻松识别。(D) 手动挑取并转移至 KnockOut SR 培养基后的 iPSC 克隆。


直接从血细胞生成 iPSC

iPS colonies in 4 different cell culture dishes made visible via alkaline phosphatase staining.

重编程克隆。使用CytoTune 2.0 试剂盒从不同体细胞来源制备诱导多能干细胞 (iPSC),并使用Essential 8 培养基在无饲养层条件下培养。


在广泛的实验中使用 CytoTune-iPS 试剂盒

点击下方选项卡,了解基因组无整合及无病毒残留如何使 CytoTune 可用于广泛的实验,包括疾病研究。

CytoTune - EmGFP Sendai 荧光报告基因

来自多种体细胞类型的成功 iPSC 重编程

以下体细胞类型已使用 CytoTune 技术成功重编程为 iPSC。

  • 成人和新生儿真皮成纤维细胞
  • 羊水 MSCs
  • 心脏成纤维细胞
  • CD34+ 血细胞
  • 乳腺上皮细胞
  • 鼻腔上皮细胞
  • 外周血单核细胞(PBMCs)
  • 骨骼肌母细胞
  • T细胞
  • 脐静脉上皮细胞
  • 尿道上皮细胞

非整合型 Sendai 载体与整合型载体的生命周期比较

Diagram comparing Sendai virus vector vs other vectors for cytoplasmic expression without genome integration

Sendai 病毒(SeV)是一种直径为 150–250 nm 的有包膜病毒,其基因组为单链负义 RNA。野生型 SeV 基因组上顺序排列着编码病毒蛋白的六个基因,顺序如下。

核衣壳蛋白(NP)与基因组 RNA 形成核心核衣壳复合物。磷蛋白(P)是 RNA 聚合酶的小亚基。基质蛋白(M)从内部支撑包膜结构。当病毒进入细胞时,融合蛋白(F)使病毒包膜与细胞膜融合。编码 F 蛋白的基因已从 CytoTune-iPS Sendai 重编程试剂盒载体中删除,因此其无法在感染细胞中产生感染性颗粒。

血凝素-神经氨酸酶(HN)识别细胞表面受体——唾液酸。大蛋白(L)是 RNA 聚合酶的大亚基。

由于 SeV 通过与存在于多种不同细胞表面的唾液酸受体结合而感染细胞,因此它可以感染不同动物的多种细胞类型。病毒-细胞融合过程的发生需要蛋白 F 经蛋白酶激活。感染后,病毒在细胞质中进行基因组复制和蛋白质合成,随后子代病毒颗粒被组装并释放。

其他病毒载体,如慢病毒或逆转录病毒,复制时需要整合到宿主基因组中,因此可能会破坏被重编程细胞的基因组,使 iPSCs 及其衍生物在临床应用中不够安全,或改变基因表达模式,从而影响化合物筛选或疾病通路分析。使用 CytoTune-iPS Sendai 重编程试剂盒进行一次转导即可高效生成 iPSCs,且无基因组整合或病毒残留,从而使 iPSCs 及其衍生物可用于更广泛的研究实验。


CytoTune-iPS 试剂盒的技术资源

Product photo of CytoTune-iPS Kit

查看我们关于使用仙台病毒进行重编程的技术资源。我们提供了详细的操作规程和常见问题解答,以及技术视频,帮助您顺利完成 CytoTune 重编程之旅。

CytoTune-iPS 2.0 Sendai 重编程试剂盒

技术资源名称
方案使用 CytoTune-iPS 2.0 Sendai重编程试剂盒生成 hiPSCs
(包括在依赖饲养层和无饲养层环境中的成纤维细胞、PBMCs 和 CD34+ 细胞)
用户指南CytoTune-iPS 2.0Sendai 重编程试剂盒用户指南
(包括成纤维细胞、PBMCs 和 CD34+ 细胞重编程方案)
常见问题CytoTune-iPS 2.0 重编程试剂盒常见问题解答

向专家学习

视频 1:仙台病毒如何重编程细胞?

本视频演示了 CytoTune-iPS 仙台病毒重编程试剂盒中的仙台病毒如何将体细胞重编程为诱导多能干细胞(iPSCs)。

视频 2:Mark Tomishima 博士谈“将一切不确定性降到最低”

Sloan Kettering Institute 干细胞研究设施的 Mark Tomishima 博士介绍了其实验室如何不断改进利用不改变基因组的仙台病毒载体对细胞进行重编程的方法。这项技术可用于制备不含随机插入 DNA 的工程化 iPSC 细胞系。

视频 3:Uma Lakshmipathy 博士介绍无转基因诱导多能干细胞的生成

Uma Lakshmipathy 博士介绍了使用 CytoTune-iPS 仙台病毒重编程试剂盒,以高效率借助仙台病毒创建无整合诱导多能干细胞的工作。

视频4:思想领袖的视角——利用 iPS 细胞揭示心血管疾病

哈佛科学家 Chad Cowan 博士借助由 CytoTune 技术驱动的 iPS 细胞技术,推动糖尿病和心脏病研究的新发现。

CytoTune - EmGFP Sendai 荧光报告基因

来自多种体细胞类型的成功 iPSC 重编程

以下体细胞类型已使用 CytoTune 技术成功重编程为 iPSC。

  • 成人和新生儿真皮成纤维细胞
  • 羊水 MSCs
  • 心脏成纤维细胞
  • CD34+ 血细胞
  • 乳腺上皮细胞
  • 鼻腔上皮细胞
  • 外周血单核细胞(PBMCs)
  • 骨骼肌母细胞
  • T细胞
  • 脐静脉上皮细胞
  • 尿道上皮细胞

非整合型 Sendai 载体与整合型载体的生命周期比较

Diagram comparing Sendai virus vector vs other vectors for cytoplasmic expression without genome integration

Sendai 病毒(SeV)是一种直径为 150–250 nm 的有包膜病毒,其基因组为单链负义 RNA。野生型 SeV 基因组上顺序排列着编码病毒蛋白的六个基因,顺序如下。

核衣壳蛋白(NP)与基因组 RNA 形成核心核衣壳复合物。磷蛋白(P)是 RNA 聚合酶的小亚基。基质蛋白(M)从内部支撑包膜结构。当病毒进入细胞时,融合蛋白(F)使病毒包膜与细胞膜融合。编码 F 蛋白的基因已从 CytoTune-iPS Sendai 重编程试剂盒载体中删除,因此其无法在感染细胞中产生感染性颗粒。

血凝素-神经氨酸酶(HN)识别细胞表面受体——唾液酸。大蛋白(L)是 RNA 聚合酶的大亚基。

由于 SeV 通过与存在于多种不同细胞表面的唾液酸受体结合而感染细胞,因此它可以感染不同动物的多种细胞类型。病毒-细胞融合过程的发生需要蛋白 F 经蛋白酶激活。感染后,病毒在细胞质中进行基因组复制和蛋白质合成,随后子代病毒颗粒被组装并释放。

其他病毒载体,如慢病毒或逆转录病毒,复制时需要整合到宿主基因组中,因此可能会破坏被重编程细胞的基因组,使 iPSCs 及其衍生物在临床应用中不够安全,或改变基因表达模式,从而影响化合物筛选或疾病通路分析。使用 CytoTune-iPS Sendai 重编程试剂盒进行一次转导即可高效生成 iPSCs,且无基因组整合或病毒残留,从而使 iPSCs 及其衍生物可用于更广泛的研究实验。


CytoTune-iPS 试剂盒的技术资源

Product photo of CytoTune-iPS Kit

查看我们关于使用仙台病毒进行重编程的技术资源。我们提供了详细的操作规程和常见问题解答,以及技术视频,帮助您顺利完成 CytoTune 重编程之旅。

CytoTune-iPS 2.0 Sendai 重编程试剂盒

技术资源名称
方案使用 CytoTune-iPS 2.0 Sendai重编程试剂盒生成 hiPSCs
(包括在依赖饲养层和无饲养层环境中的成纤维细胞、PBMCs 和 CD34+ 细胞)
用户指南CytoTune-iPS 2.0Sendai 重编程试剂盒用户指南
(包括成纤维细胞、PBMCs 和 CD34+ 细胞重编程方案)
常见问题CytoTune-iPS 2.0 重编程试剂盒常见问题解答

向专家学习

视频 1:仙台病毒如何重编程细胞?

本视频演示了 CytoTune-iPS 仙台病毒重编程试剂盒中的仙台病毒如何将体细胞重编程为诱导多能干细胞(iPSCs)。

视频 2:Mark Tomishima 博士谈“将一切不确定性降到最低”

Sloan Kettering Institute 干细胞研究设施的 Mark Tomishima 博士介绍了其实验室如何不断改进利用不改变基因组的仙台病毒载体对细胞进行重编程的方法。这项技术可用于制备不含随机插入 DNA 的工程化 iPSC 细胞系。

视频 3:Uma Lakshmipathy 博士介绍无转基因诱导多能干细胞的生成

Uma Lakshmipathy 博士介绍了使用 CytoTune-iPS 仙台病毒重编程试剂盒,以高效率借助仙台病毒创建无整合诱导多能干细胞的工作。

视频4:思想领袖的视角——利用 iPS 细胞揭示心血管疾病

哈佛科学家 Chad Cowan 博士借助由 CytoTune 技术驱动的 iPS 细胞技术,推动糖尿病和心脏病研究的新发现。


引用用于 iPSC 生成的仙台病毒的出版物

以下为主要文献引用列表(按年份排序)

Year细胞类型文献物种
2020Blood cellsDeslauriers A.G., et al. (2021) Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells. In: Cobaleda C., Sánchez-García I. (eds) Leukemia Stem Cells. Methods in Molecular Biology, vol 2185. Humana, New York, NY
2020Cells from placental artery endothelium (PL)Isono, W. et al. (2020) The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions. Regenerative Therapy Vol 15 December 2020, Pages 161-168
2020CD34+ bone marrow cellsLee, S.-J et al. (2020) Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium. Data in Brief Vol 32 October 2020, 106140
2020FibroblastVasylovska, S. et al. Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors. Stem Cell Res 9 December 2020, 102114 (online)
2020PMBCLim, SW. et al. (2020) Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman’s syndrome. Stem Cell Res 4 December 2020, 102110 (online)
2020PMBCChu, E.P-F. et al. (2020) Generation of three induced pluripotent stem cell lines from type 2 diabetic patients with ocular complications. Stem Cell Res Vol 49 December 2020, 102109
2020PMBCBarnabei, L. et al. (2020) Generation of an iPSC line (IMAGINi011-A) from a patient carrying a STING mutation. Stem Cell Res 2 December 2020, 102107 (online)
2020PBMCBarbeau, S. et al. (2020) Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQ. Stem Cell Res Vol 49 December 2020, 102106
2020FibroblastBono, F. et al. (2020) Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression. Stem Cell Res Vol 49 December 2020, 102104
2020FibroblastDing, Y. et al. (2020) Derivation of iPSC lines from three young healthy donors of Caucasian origin (NUIGi035-A; NUIGi036-A; NUIGi037-A). Stem Cell Res Vol 49 December 2020, 102101
2020PBMCYamasaki, AE. et al. (2020) An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects. Stem Cell Res Vol 49 December 2020, 102096
2020PBMCSouidi, M. et al. (2020) Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). Stem Cell Res Vol 49 December 2020, 102094
2020PBMCYan, R. et al. (2020) Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene. Stem Cell Res Vol 49 December 2020, 102091
2020PBMCZhu, YJ. et al. (2020) Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res 49 December 2020, 102088
2020Urine cellsGuo, X et al. (2020) Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient. Stem Cell Res Vol 49 December 2020, 102085
2020FibroblastMukherjee, S. et al. (2020) Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells. Stem Cell Res Vol 49 December 2020, 102084
2020FibroblastScalise, S. et al. (2020) Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene. Stem Cell Res Vol 49 December 2020, 102083
2020FibroblastInglés-Ferrándiz, M. et al. (2020) Generation, establishment and characterization of a pluripotent stem cell line (CVTTHi001-A) from primary 成纤维细胞 isolated from a patient with activated PI3 kinase delta syndrome (APDS2). Stem Cell Res 49 December 2020, 102082
2020FibroblastSchuster, J. et al. (2020) Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21). Stem Cell Res Vol 49 December 2020, 102081
2020PBMCGong, P. et al. (2020) Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation. Stem Cell Res Vol 49 December 2020, 102080
2020FibroblastVölkner, C. et al. (2020) Generation of an iPSC line (AKOSi006-A) from 成纤维细胞 of an NPC1 patient, carrying the homozygous mutation p.I1061T (c.3182 T > C) and a control iPSC line (AKOSi007-A) using a non-integrating Sendai virus system. Stem Cell Res Vol 49 December 2020, 102056
2020PBMCBing, S. et al. (2020) Generation of induced pluripotent stem cell GZHMCi002-A from peripheral blood mononuclear cells with APOB mutation. Stem Cell Res Vol 49 December 2020, 102054
2020PBMCZhu, S. et al. (2020) Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation. Stem Cell Res Vol 49 December 2020, 102040
2020PBMCMathieu, F. et al. (2020) Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor. Stem Cell Res Vol 49 December 2020, 102037
2020CellsSteeg, R. et al. (2020) The EBiSC iPSC bank for disease studies. Stem Cell Res Vol 49 December 2020, 102034
2020PBMCLin, H.-Y., et al. (2020) Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene. Stem Cell Res Vol 49 December 2020, 102032
2020PBMCOu-Yang, C.-H et al. (2020) Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene. Stem Cell Res Vol 49 December 2020, 102031
2020CD34+ bone marrow cellsLee, S.-J. et al. (2020) Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation. Stem Cell Res Vol 49 December 2020, 102030
2020PMBCChu, E.P-F. et al. (2020) Establishment of three human induced pluripotent stem cell lines from a type 1 diabetic family harboring sequence variants associated with autoimmunity. Stem Cell Res Vol 49 December 2020, 102029
2020FibroblastLuo, F. et al. (2020) Developmental deficits and early signs of neurodegeneration revealed by PD patient derived dopamine neurons. Stem Cell Res Vol 49 December 2020, 102027
2020Renal Epithelial CellsSu, J. et al. (2020) Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent. Stem Cell Res Vol 49 December 2020, 102021
2020PBMCBozaoglu, K. et al. (2020) Generation of four iPSC lines from Neurofibromatosis Type 1 patients. Stem Cell Res Vol 49 December 2020, 102013
2020FibroblastXiu, X. et al. (2020) Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from 成纤维细胞 of four healthy individuals. Stem Cell Res Vol 49 December 2020, 102011
2020FibroblastAli, E. et al. (2020) Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene. Stem Cell Res Vol 49 December 2020, 102007
2020Bone marrow-derived mesenchymal stem cells; Adipose tissue-derived mesenchymal stem cells; Wharton’s Jelly-derived mesenchymal stem cellsAbabneh, N.A et al. (2020) Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton’s jelly samples. Stem Cell Res Vol 49 December 2020, 102000
2020FibroblastGe, N. et al. (2020) Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Stem Cell Res Vol 49 December 2020, 101997
2020FibroblastGe, N. et al. (2020) Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal 成纤维细胞 of a healthy individual. Stem Cell Res Vol 49 December 2020, 101996
2020PBMCDatta, I. et al. (2020) Generation of induced pluripotent stem cells (NIMHi002-A and NIMHi003-A) from two sporadic Parkinson's disease patient of East Indian ethnicity. Stem Cell Res Vol 49 December 2020, 101995
2020PBMCZhu, X. et al. (2020) Generation of induced pluripotent stem cells (NJDTHi001-A) from a Danon disease child with mutation of c.467 T > G in LAMP2 gene. Stem Cell Res Vol 49 December 2020, 101994
2020FibroblastRatti, A. et al. (2020) Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS 成纤维细胞 and iPSC-motoneurons. Neurobiology of Disease Vol 145 November 2020, 105051
2020FibroblastUcuncu, E.,  et al. (2020)  MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia. Nat Commun 11, 6087 (2020)
2020FibroblastCastel, G. et al. (2020) Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells. Volume 33, Issue 8, 24 November 2020, 108419
2020Epidermal KeratinocytesChang, YH. et al. (2020) Induced Pluripotent Stem Cell-Differentiated Chondrocytes Repair Cartilage Defect in a Rabbit Osteoarthritis Model. Stem Cell International, 10 November 2020
2020成纤维细胞Smirnikhina, SA. et al. (2020) P.F508del editing in cells from cystic fibrosis patients. PLoS ONE 15(11): e0242094.
2020CD34+ bone marrow cellsTan, C. et al. (2020) Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5′-UTR of the ANKRD26 gene. Stem Cell Res Vol 48 October 2020, 102002
2020Myoblasts & PBMCMetzler, E. et al. (2020) Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor. Stem Cell Res Vol 48 October 2020, 101998
2020PBMCVaidyanath, A. et al. (2020) Establishment of integration free iPSC clones, NCCSi011-A and NCCSi011-B from a liver cirrhosis patient of Indian origin with hepatic encephalopathy. Stem Cell Res Vol 48 October 2020, 101992
2020PBMCAqel, Y. et al. (2020) Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene. Stem Cell Res Vol 48 October 2020, 101991
2020CD34+ cells (from PBMC)Sahabian, A. et al. (2020) Generation of two hiPSC clones (MHHi019-A, MHHi019-B) from a primary ciliary dyskinesia patient carrying a homozygous deletion in the NME5 gene (c.415delA (p.Ile139Tyrfs*8)). Stem Cell Res Vol 48 October 2020, 101988
2020Myoblasts & PBMCMetzler, E. et al. (2020) Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor. Stem Cell Res Vol 48 October 2020, 101987
2020FibroblastRolova, T. et al. (2020) Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer’s disease. Stem Cell Res Vol 48 October 2020, 101968
2020FibroblastAbabneh, N.A et al. (2020) Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem Cell Res Vol 48 October 2020, 101967
2020PBMCLiu, S. et al. (2020) Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual. Stem Cell Res Vol 48 October 2020, 101966
2020FibroblastZhou, D. et al. (2020) Generation of an induced pluripotent stem cell line from the dermal 成纤维细胞 of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation. Stem Cell Res Vol 48 October 2020, 101965
2020PBMCSequiera, G.L et al. (2020) Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene. Stem Cell Res Vol 48 October 2020, 101964
2020PBMCQuelennec, E. et al. (2020) Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors. Stem Cell Res Vol 48 October 2020, 101959
2020成纤维细胞Ratnavadivel, S. et al. (2020) Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L. Stem Cell Res Vol 48 October 2020, 101957
2020FibroblastWang, W. et al. (2020) Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease. Stem Cell Res Vol 48 October 2020, 101937
2020PBMCBanal, C. et al. (2020) Generation of an iPSC line (IMAGINi022-A) from a patient carrying a SOX10 missense mutation and presenting with deafness, depigmentation and progressive neurological impairment. Stem Cell Res Vol 48 October 2020, 101936
2020PBMCSequiera, G.L et al. (2020) Establishment of variant free-iPSC (UOMi003-A) line from patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Stem Cell Res Vol 48 October 2020, 101935
2020PBMCSequiera, G.L et al. (2020) Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene. Stem Cell Res Vol 48 October 2020, 101934
2020FibroblastKondrateva, E. et al. (2020) Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin 成纤维细胞 of a cystic fibrosis patient with p.F508del mutation. Stem Cell Res Vol 48 October 2020, 101933
2020Umbilical cord bloodLu, JZ. et al. (2020) An induced pluripotent stem cell line (EHTJUi002-A) derived from a neonate with c.678G>A mutation in the gene FZD4 causing exudative vitreoretinopathy. Stem Cell Res Vol 48 October 2020, 101932
2020FibroblastCosset, E. et al. (2020) Generation of human induced pluripotent stem cell line UNIGEi003-A from skin 成纤维细胞 of an apparently healthy male donor. Stem Cell Res Vol 48 October 2020, 101928
2020FibroblastBeh, ST. et al. (2020) Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research. Cells 2020, 9, 2383 (30 October 2020)
2020FibroblastRamos-Gonzalez, P. et al. (2020) Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation. Research Square
2020CellsMcQuade, A., et al. (2020) Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease. Nat Commun 11, 5370 (2020)
2020FibroblastBeltran, A. A., et al. (2020). Derivation of Induced Pluripotent Stem Cells from Human 成纤维细胞 Using a Non-integrative System in Feeder-free Conditions. Bio-protocol 10(20): e3788.
2020FibroblastOh, KJ. et al. (2020) Derivation of induced pluripotent stem cell lines from New Zealand donors, Journal of the Royal Society of New Zealand 18 October 2020
2020T-cellsAkamine S, et al. (2020) GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons. The FASEB Journal. 2020;34:16601–16621
2020FibroblastUrresti, J. et al. (2020) Cortical Organoids Model Early Brain Development Disrupted by 16p11.2 Copy Number Variants in Autism. bioRxiv, 6 October 2020
2020FibroblastPedrosa, CDSG. et al. (2020) Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres. Preprint. bioRxiv. 2020;2020.09.11.293951. Published 2020 Oct 9.
2020FibroblastTobias, I. et al. (2020) Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases. Research SquareCanine
2020Prostate cancer cellsZhang, Y. et al. (2020) Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research. Cellular Reprogramming Vol 22, No 5, 30 Sept 2020
2020成纤维细胞Shibamiya, A. et al. (2020). Cell banking of hiPSCs: A practical guide to cryopreservation and quality control in basic research. Current Protocols in Stem Cell Biology, 55, e127
2020Cells from fetal lung tissueKunisaki, SM et al. (2020) Human induced pluripotent stem cell‐derived lung organoids in an ex vivo model of the congenital diaphragmatic hernia fetal lung. Fetal and Neonatal Stem Cells 19 Sept 2020
2020CellsKumar, M et al. (2020) Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons. Volume 15, Issue 3, 8 September 2020, Pages 629-645
2020CellsHuang, CY. et al. (2020) Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank. J Biomed Sci 27, 92 (2020).
2020FibroblastKohama, Y. et al. (2020) Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes. Sci Rep 10, 15348 (2020
2020FibroblastCowan, C.S. et al. (2020) Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution. Volume 182, Issue 6, 17 September 2020, Pages 1623-1640.e34
2020FibroblastPatel, A. et al. (2020) Establishment and characterization of two iPSC lines derived from healthy controls. Stem Cell Res Vol 47 August 2020, 101926
2020FibroblastAbabneh, N.A et al. (2020) Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene. Stem Cell Vol 48 October 2020, 101925
2020FibroblastAbabneh, N.A et al (2020) Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi011-A) from skin 成纤维细胞 of a healthy Jordanian male subject. Stem Cell Res Vol 48 October 2020, 101923
2020FibroblastTobias, I. et al. (2020) Targeted expression profiling reveals distinct stages of early canine fibroblast reprogramming are regulated by 2-oxoglutarate hydroxylases. Research SquareCanine
2020成纤维细胞Klofas, LK et al. (2020) DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. Neurobiology of Disease, Vol 143 September 2020, 104975
2020成纤维细胞Chen D, et al (2020) Human induced pluripotent stem cells generated from a patient with a homozygous L272P mutation in the OTULIN gene (NIHTVBi014-A). Stem Cell Res Vol 47 August 2020, 101921
2020PBMCChen X, et al (2020) An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene. Stem Cell Res Vol 47 August 2020, 101919
2020PBMCVallejo-Diez S, et al (2020) Generation of one iPSC line (IMEDEAi007-A) by Sendai Virus transduction of PBMCs from a Psoriasis donor. Stem Cell Res Vol 47 August 2020, 101917
2020PBMCNiu S, et al (2020) Generation of patient-specific induced pluripotent stem cells (ZZUSAHi001-A) derived from a familial atrial fibrillation patient carrying KCNA5 c.775G>A mutation. Stem Cell Res Vol 47, August 2020, 101915
2020CD 34+Lee SJ, et al (2020) Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium. Stem Cell Res Vol 47 August 2020, 101913
2020PBMCZhang Y, et al (2020) Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L275F mutation. Stem Cell Res Vol 47 August 2020, 101912
2020CD4+ T-cellsVaidyanath A, et al (2020) Development and characterization of two independent integration free iPSC clones NCCSi010-A and NCCSi010-B from a patient with alcoholic liver cirrhosis of Indian ethnicity. Stem Cell Res Vol 47 August 2020, 101911
2020PBMCFukunaga I, et al (2020) Generation of two induced pluripotent stem cell lines from PBMCs of siblings carrying c.235delC mutation in the GJB2 gene associated with sensorineural hearing loss. Stem Cell Res Vol August 2020, 101910
2020FibroblastAbabneh, N.A. et al. (2020) Establishment of (JUCTCi007-A) iPSC line from a patient with congenital myasthenic syndrome (CMS) carrying a homozygous mutation p.Arg331Trp (c.991C > T) in the CHRNE gene. Stem Cell Res Vol 47 August 2020, 101906
2020PBMCYan, Y. et al. (2020) Generation of a human iPSC line CIBi007-A from a patient with young-onset Parkinson’s disease carrying variants in PRKN and HTRA2. Stem Cell Vol Vol 47 August 2020, 101905
2020PBMCRebs, S. et al. (2020) Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation. Stem Cell Res Vol 47 August 2020, 101901
2020PBMCNengqing L, et al (2020) Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation. Stem Cell Res Vol 47 August 2020, 101897
2020PBMCPerepelina, K et al (2020) Generation of two iPSC lines (FAMRCi007-A and FAMRCi007-B) from patient with Emery–Dreifuss muscular dystrophy and heart rhythm abnormalities carrying genetic variant LMNA p.Arg249Gln. Stem Cell Res Vol 47 August 2020, 101895
2020CellsSinha et al. (2020) Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy, The American Journal of Human Genetics August 6, 2020
2020CellsWarre-Cornish, K. et al. (2020) Interferon-γ signaling in human iPSC–derived neurons recapitulates neurodevelopmental disorder phenotypes. Sci. Adv. 2020; 6 : eaay9506 19 August 2020
2020FibroblastMazzara, PG. et al. (2020) Frataxin gene editing rescues Friedreich’s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons. Nat Commun 11, 4178 (2020)
2020FibroblastRichard P. et al. (2020) SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation, Autophagy, 7 August 2020
2020FibroblastHo, MF. et al (2020) TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. Mol Psychiatry (2020)
2020T-cellsLandon, M. et al. (2020) Establishing consistent methods for the generation of donor-derived iPSCs from T cell subsets [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl): Abstract nr 488.
2020FibroblastSalikhova, D. et al. (2020) Secretome-Mediated Neuroprotective Effects of the hiPSC-derived Glial and Neuronal Progenitor Cells in the Hypoxia-Induced Neuronal Damage (Comparative Study). Research Square
2020DPSC (Dental Pulp Stem Cells)Bosch, B. et al. (2020) A new alternative for corneal endothelial regeneration using autologous dental pulp stem cells. Research Square
2020Fibroblast, PBMCOlivia Krefft, 30 September 2020: Unraveling the pathology of different disease severities in human cerebral organoid models of LIS1-lissencephaly. Dissertation
2020FibroblastSimon Alexander Sumer, 29. September 2020: Deciphering the role of SHOX2 in atrial fibrillation and sinus node dysfunction. Dissertation
2020FibroblastAbabneh, NA et al (2020) Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy Jordanian female skin dermal 成纤维细胞. Stem Cell Res 47 August 101891
2020Urine cellsGuo, X et al. (2020) Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation. Stem Cell Res Vol 47 August 101886
2020Fibroblast, PBMCSerra-Vinardell, J. et al (2020) Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines. Stem Cell Res Vol 47 August 2020, 101883
2020FibroblastLi, X. et al. (2020) An integration-free iPSC line ZZUNEUi008-A derived from dermal 成纤维细胞 of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene. Stem Cell Res Vol 47 August 2020, 101882
2020Wharton’s jelly stem cells of the umbilical cordKong, CM et al (2020) Tissues derived from reprogrammed Wharton’s jelly stem cells of the umbilical cord as a platform to study gestational diabetes mellitus. Stem Cell Res Vol 47 August 2020, 101880
2020PMBCCai, Y et al (2020) Generation of a human induced pluripotent stem cell line (SHUPLi001-A) from PBMCs of a healthy male donor. Stem Cell Res Vol 47 August 2020, 101871
2020FibroblastBenabdallah, B., et al. (2020) Myogenic progenitor cells derived from human induced pluripotent stem cell are immune-tolerated in humanized mice. STEM CELLS Transl Med. 2020;1–11
2020PBMCMenara, G. et al (2020) Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from a patient with steroid-resistant nephrotic syndrome carrying the homozygous p.R138Q mutation in the podocin-encoding NPHS2 gene. Stem Cell Res Vol 46 July 2020, 101878
2020PBMCNa, DH et al (2020) Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene. Stem Cell Res Vol 46 July 2020, 101876
2020PBMCZhang, S.-J. et al (2020) Derivation of an induced pluripotent stem cell line (PUMCHi003-A) from a patient with pulmonary arterial hypertension carrying heterozygous mutation in PTGIS gene. Stem Cell Res Vol 46 July 2020, 101875
2020Renal epithelial cellsWang, J. et al (2020) Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson’s disease patient carrying a c.180_181del mutation in ATP7B gene. Stem Cell Res Vol 46 July 2020, 101873
2020PBMCWang, A. et al (2020) Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan–Herndon–Dudley syndrome. Stem Cell Res Vol 46 July 2020, 101872
2020PBMCChen, J. et al. (2020) Generation of human induced pluripotent stem cell (SKLRMi001-A) from a patient with partial androgen insensitivity syndrome (PAIS). Stem Cell Res Vol 46 July 2020, 101863
2020成纤维细胞Janz, A. et al. (2020) Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation. Stem Cell Res 46 July 2020, 101856
2020FibroblastBuers, I. et al. (2020) Crisponi syndrome/cold-induced sweating syndrome type 2: Reprogramming of CS/CISS2 individual derived 成纤维细胞 into three clones of one iPSC line. Stem Cell Res Vol 46 July 2020, 101855 
2020FibroblastArbini, A et al. (2020) Generation of three induced pluripotent stem cell (iPSC) lines from a patient with developmental epileptic encephalopathy due to the pathogenic KCNA2 variant c.869T>G; p.Leu290Arg (NUIGi052-A, NUIGi052-B, NUIGi052-C). Stem Cell Res Vol 46 July 2020, 101853
2020Cord Blood MSCBarilani, M et al. (2020) A circular RNA map for human induced pluripotent stem cells of foetal origin. eBioMedicine Vol 57 July 2020, 102848
2020FibroblastSchöning, L. et al. (2020) Generation of induced pluripotent stem cell lines from a Crisponi/Cold induced sweating syndrome type 1 individual. Stem Cell Res Vol 46 July 2020, 101820
2020Type 1 Diabetes cellsLeite NC, et al (2020) Modeling Type 1 Diabetes In Vitro using Human Pluripotent Stem Cells. Cell Reports 32, 107894, July 14 2020
2020FibroblastWalsh, P. et al. (2020) Accelerated differentiation of human pluripotent stem cells into neural lineages via an early intermediate ectoderm population. Stem Cells Vol 38:1400–1408
2020PBMCKim, KY et al (2020) Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients. Transl Neurodegener 9, 23 (2020).
2020FibroblastGrønning Hansen, M et al (2020) Grafted human pluripotent stem cell-derived cortical neurons integrate into adult human cortical neural circuitry. STEM CELLS Transl Med. 2020;9:1365–1377.
2020PBMCChristidi E, et al (2020) Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes. Scientific Reports | (2020) 10:10363
2020PBMCChristidi, E. et al (2020). Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes. Sci Rep 10, 10363 (2020)
2020PBMCSubramani, P et al (2020). Plasmodium vivax liver stage assay platforms using Indian clinical isolates. Malar J 19, 214 (2020).
2020成纤维细胞Das Sharma, S. et al. (2020) Cortical neurons derived from human pluripotent stem cells lacking FMRP display altered spontaneous firing patterns. Molecular Autism 11, 52 (2020)
2020Liver cells (hepatic non-parenchymal)Kirchner VA, et al (2020) Reprogramming of Human Hepatic Non‐Parenchymal Cells: Step‐by‐Step Protocol. Current Protocols in Stem Cell Biology 17 June 2020
2020FibroblastStrano, A et al (2020) Variable Outcomes in Neural Differentiation of Human PSCs Arise from Intrinsic Differences in Developmental Signaling Pathways. Cell Reports Vol 31, Issue 10, 9 June 2020, 107732
2020FibroblastMorival J, et al (2020) Targeted epigenetic tools for the control of variability in cardiac differentiation of patient-derived iPSCs
2020CD34+ cellsDrick N, et al (2020) Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DNAH5 gene. Stem Cell Res Vol 46 July 2020, 101848. Doi.org/10.1016/j.scr.2020.101848
2020CD34+ cellsDahlmann, J et (2020) Generation of two hiPSC lines (MHHi016-A, MHHi016-B) from a primary ciliary dyskinesia patient carrying a homozygous 5 bp duplication (c.248_252dup (p.Gly85Cysfs*11)) in exon 1 of the CCNO gene. Stem Cell Res Vol 46 July 2020, 101850. Roi.org/10.1016/j.scr.2020.101850
2020KeratinocytesLee H, et al (20202) Apolipoprotein E expression pattern in human induced pluripotent stem cells during in vitro neural induction [version 1; peer review: awaiting peer review]. F1000Research 2020, 9:353 (https://doi.org/10.12688/f1000research.23580.1)
2020FibroblastSun C, et al (2020) Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies 3 compounds that ameliorate disease in mdx mice
2020Primary LymphocytesFantuzzo, JA et al (2020) Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications. Lab on a chip, Issue 6, 2020
2020FibroblastCollino F, et al (2020) Extracellular Vesicles Derived from Induced pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model. Cells 2020, 9, 453; Doi:10.3390/cells9020453
2020FibroblastShen X, et al (2020) Progress towards drug discovery for Friedreich’s Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein. Bioorganic and Medicinal Chemistry Vol 28 Issue 11, 1 June 2020, 115472. Doi.org/10.1016/j.bmc.2020.115472
2020CellsHeaton H, et al (2020)  Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat Methods (2020). Doi.org/10.1038/s41592-020-0820-1
2020CD34+ cellsLiu H, et al (2020)  Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations. J Neurodevelop Disord 12, 14 (2020) Doi.org/10.1186/s11689-020-09317-2
2020FibroblastXian X, et (2020) et al. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells. Stem Cell Res Ther 11, 179 (2020). Doi.org/10.1186/s13287-020-01701-y
2020FibroblastLito S, (2020) In vitro modelling of neural insult in Mucopolysaccharidosis type 1 hurler using patient-derived human induced pluripotent stem cells. Thèse de doctorat : Univ. Genève, 2020, no. Sc. Méd. 38. DOI : 10.13097/archive-ouverte/unige:136222
2020PBMCKim, BY et al (2020) Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader–Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2–q13. Stem Cell Res online 20 May 2020, 101847. Doi.org/10.1016/j.scr.2020.101847
2020PBMCMui BWH, et al (2020) Generation of human induced pluripotent stem cell line (NIDCRi001-A) from a Muenke syndrome patient with an FGFR3 p.Pro250Arg mutation. Stem Cell Res online 19 May 2020, 101823. Doi.org/10.1016/j.scr.2020.101823
2020PBMCHe R et al (2020)  Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. Biol Res 53, 22 (2020). Doi.org/10.1186/s40659-020-00288-1
2020FibroblastBifari F, et al (2020) Complete neural stem cell (NSC) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism. Pharmacological Res online 12 May 2020, 104863. Doi.org/10.1016/j.phrs.2020.104863
2020PBMCWang Y, et al (2020) Induced pluripotent stem cells (SHCDNi002-A cells) isolated from the peripheral blood mononuclear cells of a 1-year-old Chinese girl with mediator complex subunit 12-related syndrome. Stem Cell Res online 8 May 2020, 101838. Doi.org/10.1016/j.scr.2020.101838
2020FibroblastHan MJ, et al (2020) Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations. Stem Cell Research online 6 May 2020, 101836 Doi.org/10.1016/j.scr.2020.101836.
2020FibroblastXiang L, et (2020)  et al. Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons. Stem Cell Rev and Rep (2020). https://doi.org/10.1007/s12015-020-09972-x
2020PBMCAli M, et al (2020)Generation and proteome profiling of PBMC-originated, iPSC-derived lentoid bodies. Stem Cell Res online 5 May 2020, 101813. Doi.org/10.1016/j.scr.2020.101813
2020PBMCFeng B, et al (2020) Induced pluripotent stem cell line derived from a sporadic amyotrophic lateral sclerosis patient. Stem Cell Res Vol 45 May 2020, 101841. Foi.org/10.1016/j.scr.2020.101841
2020FibroblastSun L, et al (2020) Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene. Stem Cell Res Vol 45 May 2020, 101833. Doi.org/10.1016/j.scr.2020.101833
2020PBMCYuan F, et al (2020) Generation of an induced pluripotent stem cell line SHCDNi001-A from a one-year-old Chinese girl with mitochondrial DNA depletion syndrome 13. Stem Cell Res Vol 45 May 2020, 101832. Doi.org/10.1016/j.scr.2020.101832
2020FibroblastOitari LE, et al (2020) Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery. Stem Cell Reports Vol. 14 924–939 May 12, 2020. Doi.org/10.1016/j.stemcr.2020.03.011
2020PBMCHuang CY, et al (2020) Establishment of an induced pluripotent stem cell (iPSC) line from a 7-year-old male patient with profound hearing loss carrying c.235delC in GJB2 gene. Stem Cell Res Vol 45 May 2020, 101795. Doi.org/10.1016/j.scr.2020.101795
2020KeratinocytesKhurana P, et al (2020) Stem Cell Research Lab Resource: Stem Cell LineInduced pluripotent stem cell (iPSC) line MLi-003A derived from an individual with the maximum number of filaggrin (FLG) tandem repeats. Stem Cell Res Vol 45 May 2020, 101827. Roi.org/10.1016/j.scr.2020.101827
2020PBMCChen G, et al (2020) Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation. Stem Cell Res Vol 45 May 2020, 101821. Doi.org/10.1016/j.scr.2020.101821
2020PMBCYan Y, et al (2020) Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene. Stem Cell Res 45 May 2020, 101792. Doi.org/10.1016/j.scr.2020.101792
2020PBMCZhang Y, et al (2020) Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene. Stem Cell Res Vol 45 May 2020, 101798 Doi.org/10.1016/j.scr.2020.101798
2020PBMCLiu CL et al (2020) Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res Vol 45 May 2020, 101784. Doi.org/10.1016/j.scr.2020.101784
2020FibroblastCiolak A, et al (2020) Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's 成纤维细胞. Stem Cell Res Vol 45 May 2020, 101796. Doi.org/10.1016/j.scr.2020.101796
2020Blood cellsVaidyanath A, et al (2020) Generation of two control iPSC clones NCCSi008-A and NCCSi008-B from an individual of Indian ethnicity. Stem Cell Res Vol 45 May 2020, 101765 Doi.org/10.1016/j.scr.2020.101765
2020CellsTang L, et al (2020) Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus Vol 142 J. of Molecular and Cellular Cardiology May 2020, Pages 53-64. Doi.org/10.1016/j.yjmcc.2020.03.016
2020FibroblastLarsen SB, et al (2020) Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35. Stem Cell Res Vol 45 May 2020, 101776. Doi.org/10.1016/j.scr.2020.101776
2020FibroblastChen M, et al (2020) Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation. Stem Cell Res Vol 45 May 2020, 101781. Doi.org/10.1016/j.scr.2020.101781
2020CellsGenova E, et al (2020) Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients. Doi.org/10.1002/cpt.1837
2020FibroblastKnottnerus SJG et al (2020) Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates. Int. J. Mol. Sci. 2020, 21, 2589. Doi.org/10.3390/ijms21072589
2020FibroblastTrembinski D.J  et al (2020) . Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction. Nat Commun 11, 2039 (2020). Doi.org/10.1038/s41467-020-15995-2
2020CellsWarre-Cornish K, et al (2020) IFNγ signalling alters neurodevelopment. bioRxiv preprint , April 21 2020. Doi.org/10.1101/789321.
2020FibroblastMun SJ, et al (2020) Long-Term Expansion of Functional Human Pluripotent Stem Cell-Derived Hepatic Organoids. International Journal of Stem Cells Published online April 30, 2020
2020CD34+ cellsSecardin L, et al (2020) TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells. Stem Cel Res Vol 44, April 2020, 101755. Doi.org/10.1016/j.scr.2020.101755
2020FibroblastYang M, et al (2020) Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis. Stem Cell Res Vol 44 April 2020, 101752 Doi.org/10.1016/j.scr.2020.101752
2020Blood cellsDatta I, et al (2020) Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant. Stem Cell Res Vol 44, April 2020, 101768. Doi.org/10.1016/j.scr.2020.101768
2020FibroblastHuo Y, et al (2020) Establishment of human induced pluripotent stem cell line from dermal 成纤维细胞 of a healthy individual. Stem Cell Res Vol 44, April 2020, 101762. doi.org/10.1016/j.scr.2020.1017622020
2020FibroblastSlot E, et al (2020) Generation of three iPSC lines from two patients with heterozygous FOXF1 mutations associated to Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins. Stem Cell Res Vol 44, April 2020, 101745. Doi.org/10.1016/j.scr.2020.101745
2020FibroblastLi R, et al (2020) An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene. Stem Cell Res April 2020, 101737. Doi.org/10.1016/j.scr.2020.101737
2020FibroblastBchetnia M, et (2020) Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene. Stem Cell Res Vol 44, April 2020, 101748. Doi.org/10.1016/j.scr.2020.101748
2020Blood cellElsayad AK, et al (2020) Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene. Stem Cell Res Vol 44, April 2020, 101736
2020PBMCLin HY, et al (2020) Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene. Stem Cell Res Vol 44, April 2020, 101734. Doi.org/10.1016/j.scr.2020.101734
2020FibroblastShuvalova LD, et (2020) Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene. Stem Cell Res Vol 44, April 2020, 101733. doi.org/10.1016/j.scr.2020.101733
2020MSCPichard L, et al (2020) Generation of human pluripotent stem cell lines (iPSCs) from mesenchymal stem cells (MSCs) from three elderly patients with osteoarthritis. Stem Cell Res Vol 44 April 2020, 101721. Doi.org/10.1016/j.scr.2020.101721
2020FibroblastOji Y, et al (2020) Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain, Volume 143, Issue 4, April 2020, Pages 1190–1205.
2020MyoblastsKatarzyna F, et al (2020) Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes. Scientific Reports (Nature Publisher Group); London Vol. 10, Iss. 1, (2020). DOI:10.1038/s41598-020-58050-2
2020FibroblastPerenthaler E, et al (2020) Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi‑allelic isoform‑specific start‑loss mutations of essential genes can cause genetic diseases. Acta Neuropathologica (2020) 139:415–442,. DOI:10.1007/s00401-019-02109-6
2020FibroblastTete G, et al (2020) New Application of Osteogenic Differentiation from HiPS Stem Cells for Evaluating the Osteogenic Potential of Nanomaterials in Dentistry. Int. J. Environ. Res. Public Health 2020, 17, 1947. Doi:10.3390/ijerph17061947
2020FibroblastStrah, N., Romano, G., Introna, C. et al. TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles. BMC Biol 18, 34 (2020). Doi.org/10.1186/s12915-020-007 
2020FibroblastLi X, et (2020) Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7. Stem Cell Res Vol 43 March 2020, 101699. Doi.org/10.1016/j.scr.2020.101699
2020PBMCFuchs N, et al (2020) Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi–Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). March 2020, 101697. Doi.org/10.1016/j.scr.2019.101697
2020CellsAlmedawar S, et al (2020) MERTK-Dependent Ensheathment of Photoreceptor Outer Segments by Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium. Stem Cell Reports j Vol. 14 j 374–389. Doi.org/10.1016/j.stemcr.2020.02.004
2020FibroblastCastro-Viñuelas R, et al (2020) Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived 成纤维细胞. Scientific Reports 10, Article number: 4272, March 6, 2020
2020FibroblastMilagre I, et al(2020) Reprogramming of Human Cells to Pluripotency Induces 2 CENP-A Chromatin Depletion. Doi.org/10.1101/2020.02.21.960252.
2020FibroblastAkkouh IA, et al (2020) Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells. Brain, Behavior, and Immunity, 25 Feb. 2020. Doi.org/10.1016/j.bbi.2020.02.008
2020CellsLegoy TA, et al (2020). In vivo Environment Swiftly Restricts Human Pancreatic Progenitors Toward Mono-Hormonal Identity via a HNF1A/HNF4A Mechanism. Cell Dev. Biol., 25 February 2020. Doi.org/10.3389/fcell.2020.00109
2020FibroblastJung ES, et al (2020) Successful Correction of ALD Patient-derived iPSCs Using CRISPR/Cas9. bioRxiv Feb. 25, 2020. Doi.org/10.1101/2020.02.23.962118.
2020FibroblastRLW Lau, et al (2020) Percutaneous intrarenal transplantation of differentiated induced pluripotent stem cells into newborn mice. American Association for Anatomy 11 Feb, 2020 Doi.org/10.1002/ar.24371Mouse
2020FibroblastZhu, W. et al (2020). Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes. Sci Rep 10, 2905 (2020). Doi.org/10.1038/s41598-020-59941-0
2020Myeloid CellsForbester JL, et al (2020) IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived 2 myeloid cells and murine models. J. Virol. Doi:10.1128/JVI.00121-20
2020PBMCEichmueller OL, et al (2020) Cerebral organoid model reveals excessive proliferation of human 4 caudal late interneuron progenitors in Tuberous Sclerosis Complex. bioRxiv preprint Feb.27, 2020. Doi.org/10.1101/2020.02.27.967802.
2020MyoblastsFiedorowicz K, et al (2020). Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes. Sci Rep 10, 1895 (2020).
2020FibroblastRatti A, et al. (2020)Induction of Chronic Stress Reveals an Interplay of Stress Granules and TDP-43 Pathological Aggregates in Human Als 成纤维细胞 and iPSC-Neurons. bioRxiv, Feb. 17, 2020. Doi.org/10.1101/2020.02.17.951434.
2020Urine cellsRobinett JC, et al (2020) Step Stretches and Shortenings Elicit Similar Transient Force Overshoots. Biophysical Journal, Vol. 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1595
2020Urine cellsRynkiewicz MJ, et al (2020) Molecular Dynamics Simulations of Alpha-Beta-Tropomyosin Show Conformational Properties of Heterodimeric Tropomyosin. Biophysical Journal Vol.118, ISSUE 3, SUPPLEMENT 1, 279A-280A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1598
2020Urine cellsLindqvist J, et al (2020) Mutations in the Large Protein Nebulin Trigger Typical Nemaline Myopathy with a Unique Molecular Mechanism. Biophysical Journal, Vol. 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1597
2020Urine cellsRahmani H, Insights into Various Types of Myopathy using the Atomic Model of Lethocerus Myosin Filaments. Biophysical Journal, Vol/ 118, ISSUE 3, SUPPLEMENT 1, 279A, FEBRUARY 07, 2020. Doi.org/10.1016/j.bpj.2019.11.1596
2020Urine cellsLuttrell S, et al (2020) Use of Cells from Remotely Collected Urine to Generate Human Induced Pluripotent Stem Cells and Myofibers that Recapitulate Unconventional Myopathies. Biophysical Journal, Vol 118, ISSUE 3, SUPPLEMENT 1, 278A-279A, FEBRUARY 07, 2020 Doi.org/10.1016/j.bpj.2019.11.1594
2020Dendritic Cells (DC)Horton C, et al (2020) Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Stem Cells 2020 Jan; 38(1): 67–79. doi: 10.1002/stem.3095Mouse
2020Cord BloodAraki, R, et al (2020). Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency. Nat Commun 11, 197 (2020). Doi.org/10.1038/s41467-019-13830-
2020Primary culture of prostate organoidsHepburn A, et al (2020) Propagation of human prostate tissue from induced pluripotent stem cells. STEM CELLS Transl Med. 2020;1–12. DOI: 10.1002/sctm.19-0286
2020PBMCBardelli D, et al (2020) Reprogramming 成纤维细胞 and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study. 21 January 2020. J Cell Mol Med. 2020;24:4051–4060. DOI: 10.1111/jcmm.15048
2019FibroblastBartusel M, (Ph.D thesis)DISRUPTION OF NEURAL CREST ENHANCER LANDSCAPES AS AN ETIOLOGICAL MECHANISM FOR HUMAN NEUROCRISTOPATHIES. Dec. 2019
2019FibroblastRen C, et al (2020) A compendious summary of Parkinson’s disease patient-derived iPSCs in the first decade. Ann Transl Med. 2019 Nov; 7(22): 685.Doi: 10.21037/atm.2019.11.16
2020FibroblastRodriguez-Traver E, et al (2010) A collection of three integration-free iPSCs derived from old male and female healthy subjects. Stem Cell Res Vol 42 January 2020, 101663. Doi.org/10.1016/j.scr.2019.101663
2020PBMCLanzi G, et al (2019) Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene. Stem Cell Res Vol 42 January 2020, 101660. Doi.org/10.1016/j.scr.2019.101660
2019Primary CellsDraper J.M., Vivian J.L. (2020) Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus. In: Larson M. (eds) Transgenic Mouse. Methods in Molecular Biology, vol 2066. Humana, New York, NY.
2019FibroblastFuellgrabe A, et al (2019) Guidelines for reporting single-cell RNA-Seq experiments
2019CellsLewallen CF, et al (2019) High-yield, automated intracellular electrophysiology in retinal pigment epithelia. Journal of Neuronal Science, Vol 328, 1 December 2019, 108442. Doi.org/10.1016/j.jneumeth.2019.108442
2019PBMCGao X, et al (2019) Establishment of induced pluripotent stem cell line (GSPHi001-A) from a 6-year old female with nephrotic syndrome. Stem Cell Res Vol 41 December 2019, 101661. Doi.org/10.1016/j.scr.2019.101661
2019FibroblastUebacher C et al (2019) Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Stem Cell Res Vol 41 December 2019, 101656. Doi.org/10.1016/J.scr.2019.101656
2019FibroblastDing Y, et al (2019) Derivation of familial iPSC lines from three ASD patients carrying NRXN1α+/– and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B). Stem Cell Res Vol 41 December 2019, 101653 Doi.org/10.1016/j.scr.2019.101653
2019FibroblastGe N, et al (2019) Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res Vol 41 December 2019, 101650. Doi.org/10.1016/j.scr.2019.101650
2019PBMCPark H, et al (2019) Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient. Stem Cell Res Vol 41 December 2019, 101648. Doi.org/10.1016/j.scr.2019.101648
2019PBMCKim BY et al (2019) Generation of patient-specific induced pluripotent stem cells (KSCBi007-A) derived from a patient with Prader–Willi syndrome retain maternal uniparental disomy (UPD). Stem Cell Res Vol 41 December 2019, 101647. Doi.org/10.1016/j.scr.2019.101647
2019FibroblastLai X, et al (2019) Generation of an induced pluripotent stem cell line (SYSUi002-A) from a patient with coronary slow flow phenomenon. Stem Cell Res Vol 41 December 2019, 101646. Doi.org/10.1016/j.scr.2019.101646
2019FibroblastDulovic-Mahlow M, et al (2019) Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease. Stem Cell Res Vol 41 December 2019, 101629. Doi.org/10.1016/j.scr.2019.101629
2019PBMCPatterson K, et al (2019) Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function. Stem Cell Res Vol 41 December 2019, 101627. Doi.org/10.1016/j.scr.2019.101627
2019FibroblastMartinez-Turrillas R, et al (2019) Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene. Stem Cell Res Vol 41 December 2019, 101626, doi.org/10.1016/j.scr.2019.101626
2019FibroblastWohlschlegel J, et al (2019) Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother. Stem Cell Res Vol 41 December 2019, 101625. Doi.org/10.1016/j.scr.2019.101625
2019FibroblastMasneri S, et al (2019) Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from 成纤维细胞 of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene. Stem Cell Res Vol 41 December 2019, 101623. Doi.org/10.1016/j.scr.2019.101623
2019PBMCKim BY, et al (2019) Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation. Stem Cell Res Vol 41 December 2019, 101622. Doi.org/10.1016/j.scr.2019.101622
2019PBMCZhang Y, et al (2019) Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene. Stem Cell Res Vol 41 December 2019, 101621. Doi.org/10.1016/j.scr.2019.101621
2019成纤维细胞Lito S, et al (2019) Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease. Stem Cell Res Vol 41 December 2019, 101604. Doi.org/10.1016/jscr.2019.101604
2019PBMCLamolda M, et al (2019) GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant. Stem Cell Res, Vol 41, December 2019, 101603. Doi.org/10.1016/j.scr.2019.101603
2019PBMCMasneri S, et al (2019) Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene. Stem Cell Res Vol 41 December 2019, 101596. Doi.org/10.1016/j.scr.2019.101596
2019FibroblastDuarte AJ et al (2019) Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene. Stem Cell Res Vol 41 December 2019, 101595.Doi.org/10.1096/j.scr.2019.101595
2019PBMCFuchs NV, et al (2019) Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Res, Vol 41 December 2019, 101592. Doi.org/10.1016/j.scr.2019.101592
2019Epidermal KeratinocytesShrestha R, et al (2019) Generation of hiPSC line TCIERi001-A from normal human epidermal keratinocytes. Stem Cell Res Vol 41, December 2019, 101590. Doi.org/10.1016/j.scr.2019.101590
2019FibroblastDiaz-Guerra E, et al (2019) An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-_4/_4 alleles. Stem Cell Res, Vol 41, December 2019, 101588. Doi.org/10.1016/j.scr.2019.101588
2019Bone barrow CellsYamasaki A, et al (2019)T wo iPSC lines generated from the bone marrow of a relapsed/refractory AML patient display normal karyotypes and myeloid differentiation potential. Stem Cell Res Vol 41 December 2019, 101587. Doi.org/10.1016/j.scr.2016.101587
2019PBMCYingjun X, et al (2019) Generation of four induced pluripotent stem cell lines, GZWWTi001-A, GZWTZi001-A, GZWXYi001-A, and GZWXDi001-A, derived from peripheral blood mononuclear cells from a family with asparagine synthetase deficiency. Stem Cell Res Vol 41 December 2019, 101583. Doi.org/10.1016/j.scr.2019.101583
2019FibroblastFerraro RM, et al (2019) Generation of three iPSC lines from 成纤维细胞 of a patient with Aicardi Goutières Syndrome mutated in TREX1. Stem Cell Res, Vol 41, December 2019, 101580. Doi.org./10.1016.j.scr.2019.101580
2019FibroblastSchuster J, et al (219) Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment. Neurobiology of Disease, Vol 132, December 2019, 104583. doi.org/10/1016.j.nbd.2019.104583
2019Cells from the amniotic fluidSung TC, et al (2019) Effect of cell culture biomaterials for completely xeno-free generation of human induced pluripotent stem cells. Biomaterials 25 November 2019, 119638. Doi.org/10.1016/j.biomaterials.2019.119638
2019Urine CellsLiu, G et al. (2019) Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Stem Cell Rev and Rep p 1-30, November 23, 2019. Doi.org/10.1007/s12015-019-09935-x
2019FibroblastBjørlykke Y, et al (2019) Reprogrammed Cells Display Distinct Proteomic Signatures Associated with Colony Morphology Variability. Stem Cells International, Volume 2019, Article ID 8036035, November 18, 2019. Doi.org/10.1155/2019/8036035
2019PBMCKachamakova-Trojanowska N, et al (2019) Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young. Cells 2019, 8, 1440; November 14, 2019. doi: 10.3390/cells8111440
2019FibroblastCozzi A, et al (2019) Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging. Stem Cell Reports, Vol 13, Issue 4, 12 November 2019, Pages 832-846. Doi.org/10.1016/j.stemcr.2019.09.002
2019Urinary cellsSong J, et al (2019) Dysregulation of neuron differentiation in an autistic savant with exceptional memory. Molecular Brain, Vol 12, Article number 91, November 7, 2019. Doi.org/10.1186/s13041-019-0507-7
2019FibroblastGiorgetti E, et al (2019) Modulation of Microglia by Voluntary Exercise or CSF1R Inhibition Prevents Age-Related Loss of Functional Motor Units. Cell Reports Vol 29, Issue 6, 5 November 2019, Pages 1539-1554.e7. Doi.org/10.1016/j.celrep.2019.10.003
2019FibroblastCrutcher E et al (2019) mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome. Scientific Reports 9, Article number: 15935, November 4, 2019. Doi.org/10.1038/s41598-019-52287-2
2019FibroblastProndzynsk M, et al (2019) Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol Med (2019) e11115, November 3, 2019 Doi.org/10.15252/emmm.2019111115
2019Hepatic organoidsMun SJ, et al (2019) Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. Journal of Hepatology Vol 71, Issue 5, Nov. 2019, p 970-985. Doi.org/10.1016/j.hep.2019.06.030
2019FibroblastRodriguez-Traver E, et al (2019) Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene. Stem Cell Res, Vol 40 October 2019, 101578. Doi.org/10.1016/j.scr.2019.101578
2019FibroblastPandolfi EC, et al (2019) Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research. Stem Cell Res Vol 40, October 2019, 101576. Doi.org/10.1016/j.scr.2019.101576
2019FibroblastTeinert J, et al (2019) Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47). Stem Cell Res, Vol 40, October 2019, 101575. Doi.org/10.1016/j.scr.2019.101575
2019FibroblastDiaz-Guerra E, et al (2019) Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation. Stem Cell Res, Vol 40, October 2019, 101574. Doi.org/10.1016/j.scr.2019.101574
2019FibroblastDomingo-Prim J, et al (2019) Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene. Stem Cell Res Vol 40, October 2019, 101570. Doi.org/10.1016/j.scr.2019.101570
2019FibroblastDomingo-Prim J, et al (2019) Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene. Stem Cell Res Vol 40, October 2019, 101569. Doi.org/10.1019/j.scr.2019.101569
2019FibroblastCerrada V, et al (2019) Derivation of a human DOA iPSC line, IISHDOi006-A, with a mutation in the ACO2 gene: c.1999G>A; p.Glu667Lys. Stem Cell Res Vol 40, October 2019, 101566, doi.org/10.1016/j.scr.2019.101566
2019Blood cellsLee Y, et al (2019) Generation of a NE https://www.sciencedirect.com/science/article/pii/S1873506119301849STIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease. Stem Cell Res Vol 40 October 2019, 101554, doi.org/10.1016/j.scr.2019.101554
2019PBMCAlari V, et al. 2019 Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. Stem Cell Res, Vol 40 October 2019, 101553.Doi.org/10.1016/j.scr.2019.101553
2019PBMCChiu CC, et al (2019) Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations. Stem Cell Res Vol 40 October 2019, 101552; doi.org/10.1016/j.scr.2019.101552
2019FibroblastGe N, et al (2019) Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res Vol 41 December 2019, 101650. Doi.org/10.1016/j.scr.2019.101650
2019PBMCLanzi G, et al (2019) Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease. Stem Cell Res Vol 40, October 2019, doi.org/10.016/j.scr.2019.101548
2019PBMCLiu H, et al (2019) Establishment of a Beals syndrome patient-derived human induced pluripotent stem cell line HELPi001-A. Stem Cell Res, Vol 40 October 2019, 101535. Doi.org/10.1016/j.scr.2019.101535
2019CellsKo HJ, et al (2019) GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease. J. Clin. Med. 2019, 8, 1751 doi:10.3390/jcm8101751
2019Retinal pigment epithelial cellsHuang CY, et al (2019) Human iPSC banking: barriers and opportunities. Journal of Biomedical Science 26:87. Doi.org/10.1186/s2929-019-578-x
2019CD34+ cellsOlivier EN, et al (2019) Differentiation of Baboon (Papio anubis) Induced-Pluripotent Stem Cells into Enucleated Red Blood Cells. Cells 2019, 8(10), 1282, October 19, 2019. Doi.org/10.3390/cells8101282Baboon (Papio Anubis)
2019PBMCCheng YF, et al (2019) Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation. Stem Cell Res, Vol 40, October 2019 doi.org/10.1016/j.scr.2019.101524
2019FibroblastWoersdoerfer P. et al (2019) Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Scientific Reports 9, Article number: 1566, October 30, 201 doi.org/10.1038/s41598-019-52204-7
2019Dendritic cells (DC)Horton C, et al (2019) iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Stem Cells Journals October 17, 2019. Doi.org/10.1002/stem.3095Mouse
2019Fibroblast &Woods S, et al (2019) Generation of Human_Induced Pluripotent Stem Cells
2019FibroblastMiklas JW, et al (2019) TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes. Nature communications 10, 4671 October 11, 2019, doi.org/10.1038/s41467-019-12482-1
2019PBMCHiramatsu, N et al (2019) An analysis of monocytes and dendritic cells differentiated from human peripheral blood monocyte-derived induced pluripotent stem cells. Med Mol Morphol October 4, 2019 pp1-10. Doi.org/10.1007/s00795-019-00231-8 
2019Adipose-derived fibroblastDutton LC, et al (2019) Inducing Pluripotency in the Domestic Cat (Felis catus). Stem Cells and Development Vol 28, No 19, September 26,2019, doi/10.1089/scd.2019.0142Felius catus (Domestic Cat)
2019PBMCShlevkov E, et al (2019) A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport. Cell Reports Vol 28, Issue 12, 17 September 2019, Pages 3224-3237.e5, doi.org/10.1016/j.celrep.2019.08.035
2019FibroblastLeibel SL, et al (2019) Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy. Scientific Reports, September 17, 2019, 9: 13450. Doi.org/10.1038/s41598-019-49696-8
2019FibroblastErkilic N, et al (2019) A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells, September 11, 2019, Cells 2019, 8, 1068; doi:10.3390/cells8091068
2019Blood cellsXingjun X, et al (2019) CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells. Annals of Hematology pp 1-11. September 11, 2019. Doi.org/10.1007/s00277-019-03763-2
2019FibroblastTiihonen J, et al (2019) Sex-specific transcriptional and proteomic signatures in schizophrenia. Nature communications, September 2, 2019, doi.org/10.1038/s4146-019-11797-3
2019Cardiac cellsPianezzi E, et al (2019) Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes. BBA, Molecular Cell Research 28 August 2019, 118538, doi.org/10.1016/j.bbamcr.2019.118538
2019CellsKreutzer J, et al (2019) Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocyte. Biomechanics and Modeling in Mechanobiology, p. 1-13, August 23, 2019, doi.org/10.1007/s10237-019-01211-8
2019Blood cells and 成纤维细胞Patel AM, et al (2019) Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes. Translational Psychiatry, Vol 9, Article Number 200, August 21, 2019 doi.org/10.1038/s41398-019-0535-1
2019Autosomal dominant osteopetrosis type II (ADO2) cellsOu M, et al (2019) Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells. Stem Cell Research & Therapy Vol 10, Article number: 251, August 10, 2019, doi.org10/.1186/s13287-019-1369-8
2019Antigen-specific T-cellsNishimura T, et al (2019) Human iPSC Generation from Antigen-Specific T Cells. In Vitro Differentiation of T-cells pp 53-57, August 9, 2019
2019FibroblastAnnunziata I, et al (2019) MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat. Nature communications 10, Article number 3626, August 9, 2019, doi.org/10.1038/s41467-019-11568-0
2019FibroblastDe Angelis MT, et al (2019) Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus. J Cell Mol Med. 2019; 23:7382–7394 DOI: 10.1111/jcmm.14598
2019CD4+cellsCarbonell AU, et al (2019) Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome. Nature communications, August 6, 2019, Article number: 3529. Doi.org/10.1038/s41467-019-11437
2019CellsHuebscher D, et al (2019) A High-Throughput Method as a Diagnostic Tool for HIV Detection in Patient-Specific Induced Pluripotent Stem Cells Generated by Different Reprogramming Methods. Stem Cells International Volume 2019, Article ID 2181437, August 5, 2019 doi.org/10.1155/2019/2181437
2019LymphoblastoidPoulin H, et al (2019) Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts Vol 516, Issue 1, BBRC, 13 August 2019, Pages 222-228 doi.org/10.1016/j.bbrc.2019.05.176
2019Epidermal KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A. Stem Cell Res Vol 40 August 2019, 101527.Doi.org/10.1019/j.scr.2019.101527
2019PBMCSchuster J, et al (2019) Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations. Stem Cell Res Vol 39, August 2019, 101523 doi.org/10.1016/j.scr.2019.101523
2019FibroblastDiaz Guerra E, et al (2019) A collection of four integration-free iPSC lines derived from diagnosed sporadic Alzheimer's disease patients with different APOE alleles. Stem Cell Res Vol 39 August 2019, 101522 doi.org/10.1016/j.scr.2019.101522
2019PBMCBozaoglu K, et al (2019) Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder Stem Cell Res, Vol 39 August 2019, 101516 doi.org/10.1016/j.scr.2019.101516
2019PBMCGatinois V, et al (2019) Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length. Stem Cell Res Vol 39 August 2019, 101515 doi.org/10.1016/j.scr.2019.101515
2019Fibroblast line GM13716Kozlowska E, et al (2019) Generation of human iPS cell line IBCHi001-A from dentatorubral pallidoluysian atrophy patient's 成纤维细胞. Stem Cell Res Vol 39, August 2019, 101512 Doi.org/10.1019/j.scr.2019.101512
2019FibroblastCarreira-Arribas L et al, (2019) Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene. Stem Cell Res Vol 39, August 101503
2019FibroblastGe N, et al (2019) Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B). Stem Cell Res Vol 39, August 2019, doi.org/10.1016/j.scr.2019.101502
2019FibroblastYang S, et al (2019) An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem Cell Res Vol 39, August 101496 doi.org/10.1016/j.scr.2019.101496
2019PBMCBai X, et al (2019) Generation of an integration-free induced pluripotent stem cell line (FDEENTi003-A) from a patient with pathological myopia. Stem Cell Res, Vol 39 August 101495 doi.org/10.1016/j.scr.2019.101495
2019FibroblastTongkobpetch S, et al (2019)Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal 成纤维细胞 of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus. Stem Cell Res, Vol 39 August 101493 doi.org/10.1016/j.scr.2019.101493
2019ErythroblastGubert F, et al (2019) Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient. Stem Cell Res, Vol 39 August 2019, 101490 doi.org/10.1016/j.scr.2019.101490
2019Bone marrow mesenchymal stromal cells (MSCs)De Almeida Sampaio GL, et al (2019) Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency. Stem Cell Res, Vol 39 August 101488, doi.org/10.1016/j.scr.2019.101488
2019PBMCNetsrithong R, et al (2019) Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual. Stem Cell Res, Vol 39, August 2019, 101487 doi.org/10.1016/j.scr.2019.101487
2019FibroblastTantarungsee N, et al (2019) Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp 成纤维细胞 of a male patient with androgenetic alopecia Stem Cell Res, Vol 38, July 2019, 101486 doi.org/10.1016/j.scr.2019.101486
2019FibroblastErkilic N, et al (2019) Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy. Stem Cell Res Vol 38, July 2019, 101478, doi.org/10.1016/j.scr.2019.101478
2019FibroblastErkilic N, et al (2019) Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis. Stem Cell Res Vol 38, July 2019, 101476 doi.org/10.1016/j.scr.2019.101476 
2019Bone-marrow mesenchymal stem cells (MSC)Okur FV, et al (2019) Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods. Stem Cell Research Research & Therapy, Vol 10, 211, July 17, 2019.Doi.org/10.1186/s13287-019-1316-8
2019CellsOlivier EN, et al (2019) PSC-RED and MNC-RED: Albumin-free and low-transferrin robust erythroid differentiation protocols to produce human enucleated red blood cells. J.Exphem, Vol 75, July 2019, Pages 31-52.e15 doi.org/10.1016/j.exphem.2019.05.006
2019PBMCRonald Ng, et (2019) Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI Insight, July 25, 2019 10.1172/jci.insight.128643
2019CD34+-derived from PBMCOkumura T, et al (2019) Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector Stem Cell Research & Therapy 10, 185, June 24, 2019 doi.org/10.1186/s13287-019-1273-2
2019CD71+-derived from PBMCBlinova K, et al (2019) Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs. Clin Transl Sci (2019) 12, 687–697, June 24, 2019. doi:10.1111/cts.12674
2019CellsBooth HDE, et al (2019) RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2G2019S Parkinson's iPSC-derived astrocytes. Neurobiology of Disease Vol. 129, Sept. 2019, p.56-66, doi.org/10.1016/j.nbd.2019.05.006
2019PBMCYu SJ, et al (2019) NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats. Brain Research 1719 15 September 2019, Pages 124-132 Doi.org/10/1016/j.brainres.2019.05.040.
2019FibroblastVakili D, (2019) A Pipeline to Compare the Differential Splicing and Gene Expression Between iPSC Cells Derived from Patients and Healthy Controls. Thesis, UCL Institute for Child Health. iPSC-Project-Diss-230418.DV
2019FibroblastPolonen RP, (2019) Modelling and Drug Responses in CPVT Patient-Specific hiPSC-derived Cardiomyocyte. Tampere University Dissertations 56, May 31, 2019
2019FibroblastSchuster J, et al (2019) Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations. Stem Cell Res 38 101474, May 30, 2019, doi.org/10.1016/j.scr.2019.101474
2019CellsCornacchia D, et al (2019) Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs. Cell Stem Cell, May 30, 2019, doi.org/10.1016/j.stem.2019.05.001
2019PBMCGarcia-Delgado AB, et al (2019) Generation of a human iPS cell line (CABi003-A) from a patient with age related macular degeneration carrying the CFH Y402H polymorphism. Stem Cell Res 38 101473, May 28, 2019, doi.org/10.1016/j.scr.2019.101473
2019FibroblastZabulica M, et al (2019) Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes. Stem Cells Development, May 24, 2019, doi.org/10.1089/scd.2019.0064
2019FibroblastLopez-Marquez A, et al (2019) Generation and characterization of a human iPSC line (UAMi004-A) from a patient with propionic acidemia due to defects in the PCCB gene. Stem Cell Res 38, 101469, May 22, 2019, doi.org/10.1016/j.scr.2019.101469
2019CellsMacArthur CC, et al (2019) Generation and comprehensive characterization of induced pluripotent stem cells for translational research. Regenerative Medicine doi.org/10.2217/rme-2018-0148
2019FibroblastDomingo-Prim J, et al (2019) Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene. Stem Cell Res 101468, May 22, 2019, doi.org/10.101016/j.scr.2019.101468
2019FibroblastEsteve J, et al (2019) Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1. Stem Cell Res 101467, May 21, 2019, doi.org/10.1016/j.scr.2019.101467
2019Urine-derived cellsYan X, et al (2019) EstablishmentofCSUASOi001-A, anon-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutation. Stem Cell Res 38, 101466, May 17, 2019, doi.org/10.1016/j.scr.2019.101466
2019FibroblastBaskfield A, et al (2019) An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pickdisease type A patient carrying a heterozygous p.L302P (c.905 T > C) mutation in the SMPD1gene. Stem Cell Res 38,101461, May 15, 2019, doi.org/10.1016/j.scr.2019.10461
2019CD34+Gunes C, et al (2019) Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator. Stem Cell Reports, Vol. 12, 1–15, May 14, 2019, doi.org/10.1016/j.stemcr.2019.03.012
2019KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell line heterozygous for p.R2447X mutation in filaggrin: KCLi002-A. Stem Cell Res 38, 101461, May 13, 2019, doi.org/10.1016/j.scr.2019.101462
2019Activated & expanded T-cells from PBMCZeng J, et al (2019) Derivation of mimetic __ T cells endowed with cancer recognition receptors from reprogrammed __ T cell . PLoS One 14(5): e0216815 May 9, 2019 doi.org/10.1371/journal.pone.0216815
2019PBMCBai X, et al (2019) Establishment of an induced pluripotent stem cell line (FDEENTi002-A) from a patient with Best's disease carrying c.888C_>_A mutation in BEST1 gene. Stem Cell Res 101459, May 9, 2019 doi.org/10.1016/j.scr.2019.101459
2019FibroblastBolinches-Amorós A, et al (2019) Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling Stem Cell Res 38, 101455, May 4, 2019, doi.org/10.1016/j.scr.2019.101455
2019PBMCGubert F, et al (2019) Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects Stem Cell Res 37 101448, May 4, 2019, doi.org/10.1016/j.scr.2019101448
2019CD34+Beke A, et al (2019) Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia. Haematologica 104, May 2, 2019; doi:10.3324/haematol.2018.208488
2019FibroblastPontis J, et al (2019) Hominoid-Specific Transposable Elements and KZFPs Facilitate Human Embryonic Genome Activation and Control Transcription in Naive Human ESCs. Cell Stem Cell 24, 724–735, May 2, 2019 doi.org/10.1016/j.stem.2019.03.012
2019FibroblastSpyrou J, et al (2019) Metabolomic and transcriptional analyses reveal atmospheric oxygen during human induced pluripotent stem cell generation impairs metabolic reprogramming. Stem Cells April 20, 2019; doi.org/10.1002/stem.3029
2019PBMCLin HI, et al (2019) Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation. Stem Cell Res 37, 101447, May 2019, doi.org/10.1016/j.scr.2019.101447
2019PBMCMontes R, et al (2019) GENYOi004-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with autism-related ADNP syndrome carrying a pTyr719*mutation. Stem Cell Res 37 101446; April 22, 2019; doi.org/10.1016/j.scr.2019101446
2019CD34+Donada A, et al (2019) Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity. Blood 133(16):1778-1788; April 19, 2019; doi.org/10.1182/blood-2018-07-861427.
2019FibroblastMonzo Al, et al (2019) Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene. Stem Cell Res 37, 101438, April 15, 2019, doi.org/10.1026/j.scr.2019.101438
2019FibroblastHiroso T, et al (2019) ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. JClin Invest; 129(5):2145-2162, April 15, 2019 doi.org/10.1172/JCI79990
2019FibroblastSobol, M, et al. (2019) Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions Mol Neurobiol 1585-3. April 13, 2019 doi.org/10.1007/s12035-019-1585-3
2019FibroblastBaskfield A, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation ofp.L43_A44delLA in theSMPD1gene. Stem Cell Res 37, 101436, April 12, 2019, doi.org/10.1016/j.scr.2019.101436
2019FibroblastLenz D, et al (2019) Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations inSCYL1. Stem Cell Res 37, 101428, March 22, 2019, doi.org/10.1016/jscr.2019.101428
2019FibroblastYeon GB, et (2019) Generation of an induced pluripotent stem cell (iPSC) line from a 42-year-old adult cerebral type X-linked adrenoleukodystrophy (X-ALD) patient. Stem Cell Res 36, 101425, March 21, 2019, doi.org/10.1016/j.scr.2019.101425
2019PBMCDe La Cerda Bm, et (2019) Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31gene. Stem Cell Res 36, 101426, March 20, 2019, doi.org/10.1016/j.scr.2019.101426
2019FibroblastSoeda S, et al (2019) Neuronal differentiation defects in induced pluripotent stem cells derived from a Prader-Willi syndrome patient. Neuroscience Letters 703, 162-167, March 19, 2019; doi.org/10.2016/j.neulet.2019.03.029
2019KeratinocytesKolundzic N, et al (2019) Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype. Stem Cell Res 37, 101424, March 14, 2019, doi.org/10.1016/j.scr.2019.101424
2019FibroblastWei X, et al (2019) Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells Sci. Adv. 2019; 5: eaau7887 13 March 2019, DOI: 10.1126/sciadv.aau7887
2019FibroblastOrtuño-Costela M, et al (2019) Derivation of an aged mouse induced pluripotent stem cell line, IISHDOi005-A. Stem Cell Research 2019, March 12, 36:101418, doi.org/10.1016/j.scr.2019.101418
2019FibroblastJung-Klawitter S, et al (2019) Generation of 2 iPSC clones from a patient with DNAJC12 deficiency: DHMCi003-A and DHMCi003-B. Stem Cell Res 2019, March 8, 36: 101402, doi.org/10.2016/j.scr.2019.101402
2019FibroblastHosaka C, et al (2019) Induced pluripotent stem cell_derived melanocyte precursor cells undergoing differentiation into melanocytes, Wiley Online Library March 6, 2019doi.org/10.1111/pcmr.12779
2019Aortic endothelial cellsOng SB, et (2019) Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy. Stem Cell Reports Vol. 12, 597–610 March 5, 2019, doi.org/10.2016/j.stemcr.2019.01.017
2019Hematopoietic stem cellsWang K, et al (2019) Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells Cell Reports 26, 2580–2592 March 5, 2019 doi.org/10.1016/j.celrep.2019.02.021
2019Urine-derived cellsChen X, et al (2019) Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds Cell Death and Disease (2019) 10:220, 220, March 5, 2019 doi.org/10.1038/s41419-019-1461-0
2019FibroblastRiera M, et al (2019) Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations. Stem Cell Res March 2019, 101385, doi.org/10.1016/j.scr.2019.101385
2019FibroblastClippinger SR, et al (2019) Disrupted Mechanobiology Links the Molecular and Cellular 2 Phenotypes in Familial Dilated Cardiomyopathy dx.doi.org/10.1101/555391
2019PBMCMajolo F, et al (2019) Important advances in Alzheimer's disease from the use of induced pluripotent stem cells JBC 26:15 doi.org/10.1186/s12929-019-0501-5
2019Cord blood CD133+ cellsArellano-Viera E, et al (2019) Generation of two transgene-free human iPSC lines from CD133+ cord blood cells. Stem Cell Res 36 (2019) 101410, Feb 28. 2019, doi.org/10.2016/j.scr.2019.101410
2019FibroblastLi X, et al (2019) Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. Stem Cell Res 36 (2019) 101414, Feb.2; doi.org/10.1016/j.scr.2019.101414
2019成纤维细胞Li R, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene Stem, Feb. 15, 2019, Cell Res 36 101408 doi.org/10.1016/j.scr.2019.101408
2019Activated T-cellsDattola E, et al (2019) Development of 3D PVA scaffolds for cardiac tissue engineering and cell screening applications 10.1039/C8RA08187E (Paper) Feb 14, 2019, RSC Adv., 9, 4246-4257
2019FibroblastRiera M, et al (2019) Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations. Stem Cell Res 36 (2019) 101389 doi.org/10.1016/j.scr.2019.101389
2019FibroblastCarrio M, et al (2019) Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas. Stem Cell Reports Vol 11, 411-426, February 12, 2019, doi.org/10.2016/jstemcr2019.01.001
2019FibroblastLenz D, et al (2019) Generation of an iPSC line from a patient with infantile liver failure syndrome 2 due to mutations in NBAS: DHMCi004-A, Feb. 11, 2019;Stem Cell Res 35 (2019) 101398, doi.org/10.1016/j.scr.2019.101398
2019CD34+ /PBMCHaase A, et (2019) GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. Stem Cell Res 35 (2019) 10391, doi.org/10.2016/j.scr.2019.101294
2019成纤维细胞Kahounova Z, et (2019) Generation of human iPSCs from fetal prostate 成纤维细胞 HPrF, Feb. 7, 2019, Stem Cell Res 35 (2019) 101405 doi.org/10.2016/j.scr.2019.101405
2019Neural cellsChuang CY, et al (2019) Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology, Feb. 4, 2019. Scientific Reports volume 9, Article number: 1166 (2019) doi.org/10.1028/s41598-018-37774-2
2019FibroblastMitchell A, et al (2019) Assessment of iPSC teratogenicity throughout directed differentiation toward an alveolar-like phenotype. Stem Cell Res Jan-Feb. 2019, 105: 45-53, doi.org/10/1016/j.diff.2019.01.003
2019NeuronsVadodaria KC et (2019) Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons Molecular Psychiatry Jan 30, 2019
2019Cardiac progenitor cells (CPCs)Cuillo A, et al (2019) Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration Int. J. Mol. Sci. Jan, 29 2019, 20(3), 468; doi.org/10.3390/ijms20030468
2019成纤维细胞Lin DS, et al. (2019) Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease Cells Jan 19, 2019, 8(1),65; doi.org/10/3390/cells8010065
2019Retinal epithelial cellsDong Y, et al (2019) Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides Jan 17, 2019, Journal of International Medical Research 2019, Vol. 47(4) 1717–1730, DOI: 10.1177/0300060519829990
2019Renal carcinoma cellsJW Hwang, et al (2019) iPSC-derived Cancer Organoids Recapitulate Genomic and Phenotypic Alterations of c-met-mutated Hereditary Kidney Cancer bioRxiv Jan 11, 2019 doi.org/10.1101/518456.
2019T-cellsShigemura T, et al (2019) Mosaicism of an ELANE Mutation in an Asymptomatic Mother Journal of Clinical Immunology (2019) pp 1-6; doi.org/10.1007/s10875-018-0580-1
2019KeratinocytesShrestha R, et al (2019) Aberrant hiPSCs Derived from Human Keratinocytes Differentiate into 3D Retinal Organoids that Acquire Mature Photoreceptors Cells, 8, 36; Jan 9, 2019; doi:10.3390/cells8010036
2019CellsBaek SK, et al (2019) A Rho-Associated Coiled-Coil Containing Kinase Inhibitor, Y-27632, Improves Viability of Dissociated Single Cells, Efficiency of Colony Formation, and Cryopreservation in Porcine Pluripotent Stem Cells. Cell Reprogram 2019, Jan 8 doi.org.10/1089/cell.2018.0020Porcine
2019Cord blood mononuclear cells (CBMC)Jang Y, et al (2019) Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering; Experimental & Molecular Medicine (2019) 51:3; Jan 7 2019; doi.org/10.1038/s12276-018-0190-2
2019FibroblastAuboyer L, et (2019) Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene. Stem Cell Res 34 (2019) 101381
2019PBMCVlahos K, et (2019) Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults. Stem Cell Res 34 (2019) 101380; doi.org/10/1016.j.scr.2018.101380
2019FibroblastGustavsson N, et al (2019) Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Res 34 (2019) 101373; doi.org/10.1016/j.scr.2018.101373
2019PBMCBai X, et al (2019) Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia. Stem Cell Res 34 (2019) 101369; doi.org/10.1016/j.scr.2018.101369
2018PBMCHennig AF, et (2018) Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis. Stem Cell Res Dec. 26, 101367; doi.org/10.1016/j.scr.2018.101367
2019FibroblastLi R, et al (2019) Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res 34 (2019) 101362; doi.org/10.1016/j.scr.2018.101362
2019FibroblastNavarro AM, et al (2019) Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation. Stem Cell Res 34 (2019) 101356; doi.org/10.1016/j.scr.2018.11.017
2019FibroblastLu YQ, et al (2019) Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76). Stem Cell Res 34 (2019) 101354; doi.org/10.1016/j.scr.2018.11.015
2019PBMCPotirat P, et al (2019) An integration-free iPSC line (MUSIi008-A) derived from a patient with severe hemolytic anemia carrying compound heterozygote mutations in KLF1 gene for disease modeling. Stem Cell Res 34 (2019) 101344; doi.org/10.1016/j.scr.2018.09.021
2018PBMCZhang QJ, et al (2018) Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis Nature Communications 9, 5230, Dec. 7, 2018
2018FibroblastTai L, et al (2018) Reprogramming human dermal fibroblast into induced pluripotent stem cells using non-integrative Sendai virus for transduction Malaysian. JPathol 2018; 40(3): 325 – 329
2018FibroblastBaulier E, et al (2018) Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Res 33 (2018) 274-277; doi.org/10.1016/j.scr.2018.11.016
2018PBMCMohanty S, et (2018) Generation of Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Peripheral Blood Mononuclear Cells of Patients With Atrial Fibrillation Circulation, Nov. 5. 2018, 138; A11444
2018PBMCWu S, et (2018) Induced Pluripotent Stem Cells Promote Retinal Ganglion Cell Survival After Transplant IOVS 2018; March, 2018; 59:1571-1576; doi:10.1167/iovs.17-23648
2018PBMCEckford PDW, et al. (2018) The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF JCF 2018; March 31; JCF-01643; doi.org/10.1016/j.jcf.2018.03.013
2018成纤维细胞Battrawy IE, et al. (2018) Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. JAm Heart Assoc. 2018; March 24; 7:e0077394; doi.org/10.1161/JAHA.117.0077394
2018cellsSato C, et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System Neuron 2018; March 21; 97:1284-1298; doi.org/10.1016/j.neuron.2018.02.015
2018FetusFerrer CM, et al. (2018) An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality. Genes & Dev. 2018; March 19; 1-3; doi: 10.1101/gad.307330.117
2018N/AUlmer BM, et al (2018) Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes. Stem Cell Reports 2018 Mar 13;10(3):834-847. doi: 10.1016/j.stemcr.2018.01.039. Epub 2018 Mar 1.
2018Urine cellsSan H, et al (2018) Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human. Stem Cell Res 2018; March 09; 29:28-31; doi.org/10.1016/j.scr.2018.03.002
2018PBMCGriscelli F, et al (2018) Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion. Stem Cell Res 2018; March 07; 29:42-45; doi.org/10.1016/j.scr.2018.03.012
2018成纤维细胞Wu YT, et al (2018) Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome. Stem Cell Res 2018 Mar;27:10-14. doi: 10.1016/j.scr.2017.12.013. Epub 2017 Dec 19.
2018PBMCNavara CS, et al. (2018) Optimization of culture conditions for the derivation and propagation of baboon (Papio anubis) induced pluripotent stem cells. PLoS One 2018 Mar 1;13(3):e0193195. doi: 10.1371/journal.pone.0193195. eCollection 2018Baboon
2018成纤维细胞Wattanapanitch M, et al (2018) Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar 成纤维细胞 using Sendai viral vectors. Stem Cell Res 2018 Mar;27:105-108. doi: 10.1016/j.scr.2018.01.013. Epub 2018 Jan 9.
2018成纤维细胞Marote A. et al (2018) Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene. Stem Cell Res 2018 Mar;27:90-94. doi:10.1016/j.scr.2018.01.006. Epub 2018 Jan 4.
2018成纤维细胞Marote A, et al (2018) Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease. Stem Cell Res 2018 Mar;27:82-85. doi: 10.1016/j.scr.2018.01.007. Epub 2018 Jan 4.
2018成纤维细胞Savchenko E, et al (2018) Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease. Stem Cell Res 2018 Mar;27:78-81. doi: 10.1016/j.scr.2018.01.002. Epub 2018 Jan 4.
2018成纤维细胞Russ K, et al. (2018) Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation. Stem Cell Res 2018 Mar;27:61-64. doi: 10.1016/j.scr.2018.01.001. Epub 2018 Jan 4.
2018PBMCLuo Y, et. (2018) Generation of an induced pluripotent stem cell line from an adult male with 45,X/46,XY mosaicism. Stem Cell Res 2018 Mar;27:42-45. doi: 10.1016/j.scr.2018.01.003. Epub 2018 Jan 5.
2018成纤维细胞Iannielli A, et al. (2018) Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models Cell Rep 2018 Feb 20;22(8):2066-2079. doi: 10.1016/j.celrep.2018.01.089.
2018成纤维细胞Kreienkamp R, et (2018) A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by Progerin. Cell Rep 2018 Feb 20;22(8):2006-2015. doi: 10.1016/j.celrep.2018.01.090.
2018成纤维细胞Kroeger H, et al (2018) The unfolded protein response regulator ATF6 promotes mesodermal differentiation Sci.Signal.2018 Feb 13;11(517). pii: eaan5785. doi: 10.1126/scisignal.aan5785.
2018成纤维细胞Sahakyan V, et al (2018) Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model Sci. Rep 2018 Feb 13;8(1):2942. doi: 10.1038/s41598-018-21103-8.
2018CD34+ cellsYe L, et al. (1018) MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1. Int J Clin Exp Pathol 2018; Feb 01; 11(2):1023-1030.
2018PBMCLong C, et (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci Adv 2018 Jan 31;4(1):eaap9004. doi: 10.1126/sciadv.aap9004. eCollection 2018 Jan.
2018成纤维细胞Russell OM, et al (2018) Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo. Scientific Reports 2018; Jan 29; 8:1799 DOI:10.1038/s41598-018-20064-2.
2018成纤维细胞Romano G, et al. (2018) Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. Sci Rep. 2018 Jan 29;8(1):1809. doi: 10.1038/s41598-018-19802-3.
2018EBV immortalized lymphoblastoidsMartineau L, et al (2018) Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)200 expansion in the DMPK gene: CHUQi001-A. Stem Cell Res 2018 Jan;26:103-106. doi: 10.1016/j.scr.2017.12.010. Epub 2017 Dec 16.
2018成纤维细胞Kucherenko MM, et (2018) Stress-dependent miR-980 regulation of Rbfox1/A2bp1 promotes ribonucleoprotein granule formation and cell survival. Nat Commun 2018 Jan 22;9(1):312. doi: 10.1038/s41467-017-02757-w.
2018Keratinocytes/HairSulkowski M, et (2018) Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch. Int J Mol Sci 2018 Jan 9;19(1). pii: E197. doi: 10.3390/ijms19010197.
2018成纤维细胞Kim S, et al. (2018) GBA1 deficiency negatively affects physiological _-synuclein tetramers and related multimers. PNAS 2018; Jan 08;DOI:10.1073/pnas.1700465115.
2017成纤维细胞Rodriguez-Madoz, JR et al (2017) Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS One 2017 Dec 27;12(12):e0190275. doi: 10.1371/journal.pone.0190275. eCollection 2017.
2017成纤维细胞He J, et (2018) Generation of Induced Pluripotent Stem Cells from Patients with COL3A1 Mutations and Differentiation to Smooth Muscle Cells for ECM-Surfaceome Analyses. Methods Mol Biol 2018;1722:261-302. doi: 10.1007/978-1-4939-7553-2_17.
2017成纤维细胞Hoffman GE, et al (2017) Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains Nat. Commun 2017 Dec 20;8(1):2225. doi: 10.1038/s41467-017-02330-5.
2017成纤维细胞Walsh P, et al (2017) Defined Culture Conditions Accelerate Small-molecule-assisted Neural Induction for the Production of Neural Progenitors from Human-induced Pluripotent Stem Cells. Cell Transplant 2017 Dec;26(12):1890-1902. doi: 10.1177/0963689717737074.
2017Dental mesenchymal stem cells (SCAP, DPSCs)Tan X, et al. (2017) Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes. Biochem Biophys Res Comm. In press 05 Dec 17.
2017真皮成纤维细胞Parrotta E, et al. (2017) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy. Stem Cell Research & Therapy 2017 8:271 https://doi.org/10.1186/s13287-017-0720-1.
2017Peripheral bloodRybová J, et al. (2017) Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II. JInherit Metab Dis. 2017 Nov 22. doi: 10.1007/s10545-017-0108-5.
2017Dermal 成纤维细胞 and T-cellsOksanen M, et al. (2017) PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. Stem Cell Reports 2017 Dec 12;9(6):1885-1897. doi: 10.1016/j.stemcr.2017.10.016.
2017成纤维细胞You YR, et al. (2017) Generation of induced pluripotent stem cell (iPSC) line from a 21-year-old X-linked adrenoleukodystrophy (X-ALD) patient. Stem Cell Res 2017 Dec;25:136-138. doi: 10.1016/j.scr.2017.10.016.
2017PBMCsHsu YH, et al. (2017) Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene. Stem Cell Res 2017 Dec;25:245-249. doi: 10.1016/j.scr.2017.10.024.
2017PBMCsXu T, et al. (2017) Generation of integration-free induced pluripotent stem cell line (NJMUi001-A) from a phenylketonuria patient. Stem Cell Res 2017 Dec;25:179-182. doi: 10.1016/j.scr.2017.11.008.
2017真皮成纤维细胞Wang Y, et al. (2017) Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism. Stem Cell Res 2017 Dec;25:132-135. doi: 10.1016/j.scr.2017.10.021.
2017真皮成纤维细胞Wang Z, et al. (2017) Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation. Stem Cell Res 2017 Dec;25:213-216. doi: 10.1016/j.scr.2017.10.025.
2017PBMCsLin CH, et al. (2017) Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation. Stem Cell Res 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020.
2017PBMCsLee JJ, et al. (2017) Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation. Stem Cell Res 2017 Dec;25:83-87. doi: 10.1016/j.scr.2017.10.026.
2017Urine epithelial cellsCristo F, et al. (2017) Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration. Stem Cell Res 2017 Dec;25:152-156. doi: 10.1016/j.scr.2017.10.019.
2017PBMCsFujimori K, et al. (2017) Escape from Pluripotency via Inhibition of TGF-_/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells. Stem Cell Reports 2017 Nov 14;9(5):1675-1691. doi: 10.1016/j.stemcr.2017.09.024.
2017真皮成纤维细胞Fu S, et al. (2017) Generation of human-induced pluripotent stem cells from burn patient-derived skin 成纤维细胞 using a non-integrative method. Int J Mol Med. 2018 Jan;41(1):87-94. doi: 10.3892/ijmm.2017.3206.
2017真皮成纤维细胞Son D, et al. (2017) Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN). Stem Cell Res 2017 Dec;25:46-49. doi: 10.1016/j.scr.2017.10.003.
2017Hair follicle keratinocytesAdhya D, et al. (2017) Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach. J Neuroendocrinol 2017 Oct 12. doi: 10.1111/jne.12547. [Epub ahead of print]
2017PBMCsHo MC, et al. (2017) Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2. Stem Cell Res 2017 Dec;25:38-41. doi: 10.1016/j.scr.2017.10.005.
2017真皮成纤维细胞Duncan G, et al. (2017) Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Stem Cells Dev. 2017 Dec 1;26(23):1695-1705. doi: 10.1089/scd.2017.0172.
2017真皮成纤维细胞Terray A, et al. (2017) Establishment of an induced pluripotent stem (iPS) cell line from dermal 成纤维细胞 of an asymptomatic patient with dominant PRPF31 mutation. Stem Cell Res 2017 Dec;25:26-29. doi: 10.1016/j.scr.2017.10.007.
2017真皮成纤维细胞Russo FB, et al. (2017) Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells. Biol Psychiatry. 2017 Oct 3. pii: S0006-3223(17)32009-7. doi: 10.1016/j.biopsych.2017.09.021.
2017真皮成纤维细胞Romero-Moya D, et al. (2017) Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q10 deficiency harboring a heterozygous mutation in COQ4 gene. Stem Cell Res 2017 Oct;24:144-147. doi: 10.1016/j.scr.2016.09.007. Epub 2016 Sep 16.
2017PBMCsHuang CY, et al. (2017) Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1. Stem Cell Res 2017 Oct;24:139-143. doi: 10.1016/j.scr.2017.09.004.
2017PBMCsGriscelli F, et al. (2017) Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene. Stem Cell Res In press 14 Sep 17.
2017真皮成纤维细胞Wu J, et al. (2017) Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi). Stem Cell Res 2017 Oct; 24:102-105 https://doi.org/10.1016/j.scr.2017.08.020.
2017Amniotic fluid cellsYan J, et al. (2017) Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease. Hemoglobin 2017 Published online 24 Aug 2017 http://dx.doi.org/10.1080/03630269.2017.1353523.
2017成纤维细胞Zurita-Diaz F, et al. (2017) Establishment of a human DOA 'plus' iPSC line, IISHDOi003-A, with the mutation in the OPA1 gene: c. 1635C> A; p. Ser545Arg. Stem Cell Res 2017 Oct; 24:81-84 https://doi.org/10.1016/j.scr.2017.08.017.
2017真皮成纤维细胞Weir G, et al. (2017) Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source. Brain, awx201 https://doi.org/10.1093/brain/awx201.
2017Adipose tissue-derived mesenchymal multipotent stromal cellsKhudiakov A, et al. (2017) Generation of iPSC line from desmin-related cardiomyopathy patient carrying splice site mutation of DES gene. Stem Cell Res 2017 Oct; 24:77-80 https://doi.org/10.1016/j.scr.2017.08.015.
2017Adipose tissue-derived mesenchymal multipotent stromal cellsKhudiakov A, et al. (2017) Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene. Stem Cell Res 2017 Oct; 24:84-88 https://doi.org/10.1016/j.scr.2017.08.014.
2017PBMCsMora C, et al. (2017) Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p. D322H mutation. Stem Cell Res 2017 Oct; 24:29-32 https://doi.org/10.1016/j.scr.2017.08.009.
2017PBMCsMora C, et al. (2017) Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p. M200V mutation. Stem Cell Res 2017 Oct; 24:8-11 https://doi.org/10.1016/j.scr.2017.08.007.
2017CD34+ cellsLimia CEG, et al. (2017) Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation. Stem Cell Res 2017 Oct; 24:16-20 https://doi.org/10.1016/j.scr.2017.08.006.
2017真皮成纤维细胞Terray A, et al. (2017) Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene. Stem Cell Res 2017 Oct; 24:1-4 https://doi.org/10.1016/j.scr.2017.08.003.
2017成纤维细胞Ortuño-Costela M (2017) Establishment of a human iPSC line (IISHDOi001-A) from a patient with McArdle disease. Stem Cell Res 2017 Aug;23:188-192. doi: 10.1016/j.scr.2017.07.020. Epub 2017 Jul 28.
2017PBMCsGriscelli F, et al. (2017) Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation. Stem Cell Res 2017 Aug;23:178-181. doi: 10.1016/j.scr.2017.07.023. Epub 2017 Jul 25.
2017PBMCsBennaceur-Griscelli A, et al. (2017) Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation. Stem Cell Res 2017 Aug;23:154-157. doi: 10.1016/j.scr.2017.07.022. Epub 2017 Jul 22.
2017真皮成纤维细胞Alonso-Barroso E, et al. (2017) Generation and characterization of a human iPSC line from a patient with propionic acidemia due to defects in the PCCA gene. Stem Cell Res 2017 Aug; 23:154-157 https://doi.org/10.1016/j.scr.2017.07.022.
2017真皮成纤维细胞Uhlen E, et al. (2017) Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix. JVis Exp. 2017 Jul 7;(125). doi: 10.3791/56146.
2017真皮成纤维细胞Torriano S, et al. (2017) Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy. Hum Mol Genet. 2017 Sep 15;26(18):3573-3584. doi: 10.1093/hmg/ddx244.
2017真皮成纤维细胞Klein S, et al. (2017) A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G > A mutation, ISMMSi002-B, for disease modeling. Stem Cell Res 2017 Aug; 23:73-76 https://doi.org/10.1016/j.scr.2017.06.016.
2017真皮成纤维细胞Aguisanda F, et al. (2017) Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics. Orphanet Journal of Rare Diseases 2017 Jun 28; 12(1):120. doi: 10.1186/s13023-017-0670-9.
2017真皮成纤维细胞Brookhauser N, et al. (2017) Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells. Stem Cell Reports 2017 Jun 6;8(6):1675-1688. doi: 10.1016/j.stemcr.2017.05.019.
2017PBMCsChen Y, et al. (2017) Generation of integration-free induced pluripotent stem cells (GZHMUi001-a) by reprogramming peripheral blood mononuclear cells from a 47, XXX syndrome patient. https://doi.org/10.1016/j.scr.2017.06.002.
2017PBMCsBrookhauser N, et al. (2017) Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. https://doi.org/10.1016/j.scr.2017.06.003.
2017Stem cells from apical papilla (SCAP) and dental pulp stem cells (DPSC)Tan X, et al. (2017) Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells. PLoS One 2017 May 18;12(5):e0177832. doi: 10.1371/journal.pone.0177832. eCollection 2017.
2017真皮成纤维细胞Fields MA, 等. (2017) 细胞外基质硝化改变生长因子释放并激活人视网膜色素上皮细胞中的生物活性补体。PubMed
2017真皮成纤维细胞Uusi-Rauva K, 等(2017)来源于 CLN5 患者的诱导多能干细胞表现出神经元蜡样脂褐质沉积症的表型特征。PubMed
2017真皮成纤维细胞Gabriel B, 等(2017)生成基于 iPSC 的人脑类器官以模拟早期神经发育障碍。PubMed
2017PBMCsWarren CR, 等(2017)诱导多能干细胞分化使代谢性疾病中 GWAS 变异的功能验证成为可能。PubMed
2017真皮成纤维细胞Tavian D, et al. (2017) Generation of induced pluripotent stem cells as disease modelling of NLSDM. Mol Genet Metab 2017 May;121(1):28-34. doi: 10.1016/j.ymgme.2017.03.009. Epub 2017 Apr 3.
2017真皮成纤维细胞Chen G, et al. (2017) Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium. Methods Mol Biol2017;1590:131-137. doi: 10.1007/978-1-4939-6921-0_9.
2017尿液细胞Uhm KO 等(2017)使用非整合系统从健康供体的尿液细胞中生成了人诱导多能干细胞。干细胞研究
2017脐带血CD34+细胞Haase A 等(2017)在无动物成分条件下从人脐带血CD34+细胞生成了非转基因iPS细胞。干细胞研究
2017真皮成纤维细胞Buonocore F, et al. (2017) Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest 2017 May 1;127(5):1700-1713. doi: 10.1172/JCI91913. Epub 2017 Mar 27.
2017PBMCsLi Y, et al. (2017) Abnormal Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities. Stem Cell Reports 2017 Apr 11;8(4):883-893. doi: 10.1016/j.stemcr.2017.02.020. Epub 2017 Mar 23.
2017PBMCsVarga E, et al. (2017) Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD). Stem Cell Research 21 (2017) 16–18 http://dx.doi.org/10.1016/j.scr.2017.03.010.
2017真皮成纤维细胞Lukovic D, et al. (2017) Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene. Stem Cell Research 21 (2017) 23–25 http://dx.doi.org/10.1016/j.scr.2017.03.007.
2017真皮成纤维细胞Coppiello G, et al. (2017) Generation of Macaca fascicularis iPS cell line ATCi-MF1 from adult skin 成纤维细胞 using non-integrative Sendai viruses. Stem Cell Research Volume 21, May 2017, Pages 1–4, https://doi.org/10.1016/j.scr.2017.03.008. Macaque
2017Primary conjunctival cellsGeng Z, et al. (2017) Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. PLoS One2017 Mar 10;12(3):e0173575. doi: 10.1371/journal.pone.0173575. eCollection 2017.
2017成纤维细胞Hunihan L, et al. (2017) Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line. Stem Cell Research 2017 Apr;20:67-69. doi: 10.1016/j.scr.2017.02.017. Epub 2017 Mar 7.
2017成纤维细胞Jung-Klawitter S, et al. (2017) Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1. Stem Cell Research 2017 Apr;20:38-41. doi: 10.1016/j.scr.2017.02.010. Epub 2017 Feb 24.
2017成纤维细胞Bharathan S, et al. (2017) Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem Cell Research 2017 Apr;20:54-57. doi: 10.1016/j.scr.2017.02.006. Epub 2017 Feb 22.
2017真皮成纤维细胞Trevisan M et al. (2017) Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Int J Mol Sci 18(1) 206 doi:10.3390/ijms18010206.
2016T淋巴细胞Hashimoto A 等(2016)从杜氏肌营养不良症患者生成诱导多能干细胞,并将其诱导分化为心肌细胞。PubMed
2016PBMCsQuintana-Bustamante O 等(2016)通过仙台重编程载体从外周血单个核细胞生成患者特异性诱导多能干细胞。PubMed
2016成纤维细胞Wiley LA 等(2016)患者特异性 iPSC 和光感受器前体细胞的 cGMP 生产,用于治疗视网膜退行性失明。PubMed
2016尿路上皮细胞Rossbach B 等(2016)采用无整合的仙台病毒技术,从健康供体的尿液细胞生成一条人诱导多能干细胞系。PubMed
2016成纤维细胞, CD34+ cellsSivapatham R et al. (2016) Generation and characterization of patient-specific induced pluripotent stem cell for disease modeling. Methods in Molecular Biology 1353:25–44 doi: 10.1007/7651_2014_157.
2015成纤维细胞Beers J 等(2015)一种用于在化学定义培养条件下大规模生产无整合人诱导多能干细胞的低成本且高效重编程平台。PubMed
2015Urine-derived cellsAfzal MZ et al. (2015) Generation of Induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp (95) e52032. doi:10.3791/52032.
2015BJ 成纤维细胞, adult dermal 成纤维细胞 (HDF)Hribar KC et al. (2015) Nonlinear 3D projection printing of concave hydrogel microstructures for long-term multicellular spheroid and embryoid body culture. Lab Chip 15(11):2412–2418 doi:10.1039/c5lc00159e.
2015成年心脏成纤维细胞Zhang L 等(2015)利用由成年心脏成纤维细胞生成的诱导多能干细胞,制备患者特异性心肌细胞片并实现高植入率。PubMed
2015PBMCsSoares FA 等(2015)利用仙台病毒从外周血单个核细胞生成了人诱导多能干细胞。PubMed
2015真皮成纤维细胞Lahm H et al. (2015) Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species. Stem Cells 33(2):392–402 doi: 10.1002/stem.1872.
2015成纤维细胞Rao RA et al. (2015) Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep 5:8229 doi:10.1038/srep08229.
2015PBMCsMalchenko S et al. (2015) A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells. PLoS One 10(3):e0121707 doi:10.1371/journal.pone.0121707.
2014Peripheral mononuclear cellsFujie Y et al. (2014) New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood. PLoS One 9(12):e113052 doi:10.1371/journal.pone.0113052. eCollection 2014.Human and chimpanzee
2014人乳腺上皮细胞(HMECs),原代成纤维细胞Tokunaga K 等(2014)利用集落和细胞核形态的计算机图像分析评估人诱导多能干细胞。PubMed
2014原代成纤维细胞Schlaeger TM 等(2014)非整合性重编程方法的比较。PubMed
2014Amniotic fluid mesenchymal stromal cells (AF-MSCs)Jiang G et al (2014) Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. Stem Cells and Development 23(21):2613–2625 doi:10.1089/scd.2014.0110.
2014Finger-prick blood samplesTan HK et al. (2014) Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. Stem Cells Trans Med 3:586–598 doi:10.5966/sctm.2013-0195.
2014Umbilical vein endothelial cellsNishio M et al. (2014) Differentiation of human pluripotent stem cells into highly functional classical brown adipocytes. Methods Enzymol 537:177–97 doi:10.1016/B978-0-12-411619-1.00010-0.
2014Adult 成纤维细胞Courtot AM et al. (2014) Morphological analysis of human induced pluripotent stem cells during induced differentiation and reverse programming. BioResearch Open Access 3(5):206–216 doi:10.1089/biores.2014.0028.
2014PBMCsKishino Y 等(2014)在限定培养条件下从人外周T细胞中获得无转基因的人诱导多能干细胞。PubMed
2014Frozen non-cryoprotected dural and scalp 成纤维细胞Sproul AA et al. (2014) Generation of iPSC lines from archived non-cryoprotected biobanked dura mater. Acta Neuropathol Commun 2:4 doi:10.1186/2051–5960-2-4.
2014真皮成纤维细胞Chestkov IV et al. (2014) Patient-specific induced pluripotent stem cells for SOD1-associated amyotrophic lateral sclerosis pathogenesis studies. Acta Naturae 6(1) 54–60.
2014BJ 成纤维细胞Quintanilla RH Jr et al. (2014) CD44 Is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS ONE 9(1):e85419 doi:10.1371/journal.pone.0085419.
2014Peripheral blood T cellsTakamatsu K et al. (2014). Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13(3 Pt A):442–53 doi:10.1016/j.scr.2014.10.001.
2014成纤维细胞Choi IY 等人(2014年)使用仙台病毒从人类体细胞高效生成诱导多能干细胞。PubMed
2014成纤维细胞Burridge PW 等人(2014年)通过化学定义方法生成人体心肌细胞。PubMed
2014真皮成纤维细胞Nazor KL et al. (2014) Application of a low cost array-based technique - TAB-Array - for quantifying and mapping both 5mC and 5hmC at single base resolution in human pluripotent stem cells. Genomics 104(5):358–67 doi:10.1016/j.ygeno.2014.08.014.
2014成纤维细胞Woodard CM et al. (2014) iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep 9(4):1173–82 doi:10.1016/j.celrep.2014.10.023.
2013真皮成纤维细胞Shang L 等人(2013年)由于干细胞模型中 Wolfram 综合征的内质网应激增加而导致的β细胞功能障碍。PubMed
2013成纤维细胞Jianfeng Lu et al. (2013) Generation of integration-free and region-specific neural progenitors from primate 成纤维细胞. Cell Rep (5):1580–91 doi:10.1016/j.celrep.2013.04.004. Epub.Human and rhesus monkey
2013CD34+Wang T 等人(2013年)从人类成人外周 CD34+ 细胞衍生神经干细胞,用于神经炎症的自体模型。PubMed
2013PBMCChen IP 等人(2013)通过整合无关的仙台病毒载体对颅干骺发育不良患者外周血中的诱导多能干细胞进行重编程。PubMed
2013PBMCZhang XB (2013) Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics 11(5):264–74 doi:10.1016/j.gpb.2013.09.001. Epub.
2013MultipleBernal JA (2013) RNA based tools for nuclear reprogramming and lineage-conversion: Towards clinical applications. Cardiovasc Transl Res 6(6):956–68 doi:10.1007/s12265-013-9494-8. Epub.
2013CD34+ /PBMCYe L et al. (2013) Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai virus vectors. Stem Cells Transl Med 2(8):558-66 doi:10.5966/sctm.2013–0006. Epub.
2013PBMCChurko JM et al. (2013) Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol 1036:81–8 doi:10.1007/978-1-62703-511-8_7.
2013成纤维细胞Kahler DJ et al. (2013) Improved methods for reprogramming human dermal 成纤维细胞 using fluorescence activated cell sorting. PLoS One 8(3):e59867 doi: 10.1371/journal.pone.0059867. Epub.
2013Blood or 成纤维细胞Lieu PT et al. (2013) Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus. Methods Mol Biol 997:45–56 doi:10.1007/978-1-62703-348-0_5.
2013综述文章Malik N 等人(2013)人类 iPSC 诱导方法综述。PubMed
2013成纤维细胞, keratinocytes and iris pigmented epithelial cellsTucker BA et al. (2013) Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med 2(1):16–24 doi:10.5966/sctm.2012-0040. Epub.Human and Mouse
2013成纤维细胞Hua H et al. (2013) iPSC-derived _ cells model diabetes due to glucokinase deficiency. J Clin Invest doi:10.1172/JCI67638 Epub ahead of print.
2013成纤维细胞Menendez L et al. (2013) Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc 8(1):203–12. Epub.
2012PBMCYang W et al. (2012) iPSC reprogramming from human peripheral blood using Sendai virus mediated gene transfer. StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008–2012.
2012BloodDaheron L et al. (2012) Blood - SeV derived fibroblast generated iPSCs. StemBook [Internet] Cambridge (MA): Harvard Stem Cell Institute; 2008–2012.
2012CD34+Nishishita N 等人(2012)在朴素状态下通过单细胞克隆,在合成基质上生成无病毒诱导多能干细胞克隆。PubMed
2012Skeletal MyoblastsTrokovic R et al. (2012) Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. Stem Cells Dev 22(1):114–23. Epub.
2012成纤维细胞, cord blood cells and peripheral blood cellsKajiwara et al. (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci USA 109(31):12538–43. Epub.
2012Cord blood CD34+ cells and 成纤维细胞Kumano et al. (2012) Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 119(26):6234–42. Epub.
2012鼻上皮细胞Ono M 等人(2012)使用仙台病毒载体从人鼻上皮细胞生成诱导多能干细胞。PLoS ONE
2012成纤维细胞Kudva et al. (2012) Transgene-free disease-specific induced pluripotent stem cells from patients with Type 1 and Type 2 diabetes. Stem Cells Trans Med doi:10.5966/sctm.2011-0044.
2012成纤维细胞Jin et al. (2012) Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Trans Med doi:10.5966/sctm.2012-0005.
2012成纤维细胞Nakamura N et al. (2012) Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. Cell Reprogram 14(2):171–85.
2012成纤维细胞MacArthur C et al. (2012) Generation of human induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012:564612.
2012外周血Seki T 等(2012)利用激活的 T 细胞和仙台病毒组合,从少量人外周血中生成诱导多能干细胞。PubMed
2011MRC-5Kriks S 等(2011)源自人胚胎干细胞的多巴胺神经元可有效植入帕金森病动物模型。PubMed
2011成纤维细胞Yusa K et al. (2011) Targeted gene correction of _1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478(7369):391–4 doi:10.1038/nature10424.
2011Peripheral circulating T cellsSeki T et al. (2011) Derivation of induced pluripotent stem cells from human peripheral circulating T cells. Curr Protoc Stem Cell Biol Chapter 4:Unit4A.3.
2011成纤维细胞,CD34+ 脐带血细胞Nishikawa S 等(2011)通过温度敏感型仙台病毒载体高效生成无转基因的人诱导多能干细胞(iPSC)。PubMed
2010成纤维细胞,CD34+ 脐带血细胞Takayama N et al. (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13):2817–30 doi:10.1084/jem.20100844.
2010T细胞Seki T 等人(2010)从人类终末分化的循环 T 细胞生成诱导多能干细胞。PubMed
2009成纤维细胞Fusaki N 等人(2009)利用基于仙台病毒的载体高效诱导无转基因的人类多能干细胞;仙台病毒是一种不会整合到宿主基因组中的 RNA 病毒。PubMed 
Stylesheet for Classic Wide Template adjustments

本页上所述产品的预期用途各不相同。关于特定的预期用途声明,请参见产品标签。

仅供科研使用,不可用于诊断目的。